<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Dietary supplements for chronic gout - Andrés, M - 2021 | Cochrane Library</title> <meta content="Dietary supplements for chronic gout - Andrés, M - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010156.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Dietary supplements for chronic gout - Andrés, M - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010156.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010156.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Dietary supplements for chronic gout" name="citation_title"/> <meta content="Mariano Andrés" name="citation_author"/> <meta content="marianoandres19@hotmail.com" name="citation_author_email"/> <meta content="Francisca Sivera" name="citation_author"/> <meta content="Rachelle Buchbinder" name="citation_author"/> <meta content="Cabrini Health" name="citation_author_institution"/> <meta content="Jordi Pardo Pardo" name="citation_author"/> <meta content="Ottawa Hospital Research Institute, The Ottawa Hospital - General Campus" name="citation_author_institution"/> <meta content="Loreto Carmona" name="citation_author"/> <meta content="Instituto de Salud Musculoesquelética" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD010156.pub3" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/11/12" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010156.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010156.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010156.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Allopurinol; Dietary Supplements; *Gout [drug therapy]; Milk; Powders" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010156.pub3&amp;doi=10.1002/14651858.CD010156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="mvgXlmVk";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010156\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010156\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010156\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010156\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANT","ru","ms","ja","hr","fa","fr","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010156.pub3",title:"Dietary supplements for chronic gout",firstPublishedDate:"Nov 12, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Musculoskeletal Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=mvgXlmVk&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010156.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010156.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010156.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010156.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010156.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010156.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010156.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010156.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010156.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010156.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4435 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010156.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/full#CD010156-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/full#CD010156-sec-0086"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/full#CD010156-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/full#CD010156-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/full#CD010156-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/full#CD010156-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/full#CD010156-sec-0040"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/full#CD010156-sec-0078"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/appendices#CD010156-sec-0091"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/supinfo/CD010156StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/supinfo/CD010156StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Dietary supplements for chronic gout</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/information#CD010156-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Mariano Andrés</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/information#CD010156-cr-0005">Francisca Sivera</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/information#CD010156-cr-0006">Rachelle Buchbinder</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/information#CD010156-cr-0007">Jordi Pardo Pardo</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010156.pub3/information#CD010156-cr-0008">Loreto Carmona</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/information/en#CD010156-sec-0099">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 12 November 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010156.pub3">https://doi.org/10.1002/14651858.CD010156.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010156-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010156-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010156-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010156-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010156-abs-0011">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010156-abs-0001" lang="en"> <section id="CD010156-sec-0001"> <h3 class="title" id="CD010156-sec-0001">Background</h3> <p>Dietary supplements are frequently used for the treatment of several medical conditions, both prescribed by physicians or self administered. However, evidence of benefit and safety of these supplements is usually limited or absent. </p> </section> <section id="CD010156-sec-0002"> <h3 class="title" id="CD010156-sec-0002">Objectives</h3> <p>To assess the efficacy and safety of dietary supplementation for people with chronic gout. </p> </section> <section id="CD010156-sec-0003"> <h3 class="title" id="CD010156-sec-0003">Search methods</h3> <p>We updated the original search by searching CENTRAL, MEDLINE, Embase, CINAHL, and four trials registers (August 2020). We applied no date or language restrictions. We also handsearched the abstracts from the 2010 to 2019 American College of Rheumatology and European League against Rheumatism conferences, and checked the references of all included studies. </p> </section> <section id="CD010156-sec-0004"> <h3 class="title" id="CD010156-sec-0004">Selection criteria</h3> <p>We considered all published randomised controlled trials (RCTs) or quasi‐RCTs that compared dietary supplements with no supplements, placebo, another supplement, or pharmacological agents for adults with chronic gout for inclusion. Dietary supplements included, but were not limited to, amino acids, antioxidants, essential minerals, polyunsaturated fatty acids, prebiotic agents, probiotic agents, and vitamins. The major outcomes were acute gout flares, study withdrawal due to adverse events (AEs), serum uric acid (sUA) reduction, joint pain reduction, participant global assessment, total number of AEs, and tophus regression. </p> </section> <section id="CD010156-sec-0005"> <h3 class="title" id="CD010156-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures expected by Cochrane.</p> </section> <section id="CD010156-sec-0006"> <h3 class="title" id="CD010156-sec-0006">Main results</h3> <p>Two previously included RCTs (160 participants) met our inclusion criteria; we did not identify any new trials for this update. As these two trials evaluated different diet supplements (enriched skim milk powder (SMP) and vitamin C) with different outcomes (gout flare prevention for enriched SMP, and sUA reduction for vitamin C), we reported the results separately. </p> <p>One trial (120 participants), at unclear risk of selection and detection bias, compared SMP enriched with glycomacropeptides (GMP) with un‐enriched SMP, and with lactose, over three months. Participants were predominantly men, aged in their 50s, who had severe gout. The results for all major outcomes were imprecise, except for pain. None of the results were clinically significant. </p> <p>The frequency of acute gout attacks, measured as the number of flares per month, decreased in all three groups over the three‐month study period. The effects of enriched SMP (SMP/GMP/G600) compared with the combined control groups (SMP and lactose powder) at three months in terms of mean number of gout flares per month were not clinically significant (mean (standard deviation (SD)) flares per month: 0.49 (1.52) in SMP/GMP/G600 group versus 0.70 (1.28) in the control groups; absolute risk difference: mean difference (MD) ‐0.21 flares per month, 95% confidence interval (CI) ‐0.76 to 0.34; low‐quality evidence). </p> <p>The number of withdrawals due to adverse effects was similar between groups (7/40 in SMP/GMP/G600 group versus 11/80 in control groups; (risk ratio (RR) 1.27, 95% CI 0.53 to 3.03); there were 4% more withdrawals in the SMP/lactose groups (10% fewer to 18% more; low‐quality evidence). </p> <p>Serum uric acid reduction was similar across groups (mean (SD) ‐0.025 (0.067) mmol/L in SMP/GMP/G600 group versus ‐0.010 (0.069) in control groups; MD ‐0.01, 95% CI ‐0.04 to 0.01; low‐quality evidence). </p> <p>Pain from self‐reported gout flares (measured on a 10‐point Likert scale) improved slightly more in the GMP/G600 SMP group compared with controls (mean (SD) ‐1.97 (2.28) in SMP/GMP/G600 group versus ‐0.94 (2.25) in control groups; MD ‐1.03, 95% CI ‐1.89 to ‐0.17). This was an absolute reduction of 10% (95% CI 20% to 1% reduction; low‐quality evidence), which may not be of clinical relevance. </p> <p>The risk of adverse events was similar between groups (19/40 in SMP/GMP/G600 group versus 39/80 in control groups; RR 0.97, 95% CI 0.66 to 1.45); the absolute risk difference was 1% fewer adverse events (1% fewer to 2% more), low‐quality evidence). Gastrointestinal events such as nausea, flatulence and diarrhoea were the most commonly reported adverse effects. </p> <p>Data for participant global assessment were not available for analysis; the study did not report tophus regression. </p> <p>One trial (40 participants), at high risk of selection, performance, and detection bias, compared vitamin C alone with allopurinol, and with allopurinol plus vitamin C, in a three‐arm study. We only included data from the vitamin C versus allopurinol comparison in this review. Participants were predominantly middle‐aged men, and their severity of gout was representative of gout in general. </p> <p>Allopurinol reduced sUA levels more than vitamin C (MD 0.10 mmol/L, 95% CI 0.06 to 0.15), low‐quality evidence. The study reported no adverse events; none of the participants withdrew due to adverse events. </p> <p>The study did not assess the rate of gout attacks, joint pain reduction, participant global assessment, or tophus regression. </p> </section> <section id="CD010156-sec-0007"> <h3 class="title" id="CD010156-sec-0007">Authors' conclusions</h3> <p>While dietary supplements may be widely used for gout, this review found no high‐quality that supported or refuted the use of glycomacropeptide‐enriched skim milk powder or vitamin C for adults with chronic gout. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010156-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010156-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD010156-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD010156-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010156-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010156-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD010156-abs-0008">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD010156-abs-0007">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD010156-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD010156-abs-0013">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD010156-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD010156-abs-0004">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010156-abs-0002" lang="en"> <h3>Dietary supplements for chronic gout</h3> <p><b>What is gout, and what are dietary supplements?</b> </p> <p>Gout is caused by crystal formation in the joints, due to high uric acid levels in the blood. People have attacks of painful, warm, and swollen joints, often in the big toe. Some people develop a large buildup of crystals just beneath the skin, known as tophi. A cure can be achieved if uric acid levels in the blood return to normal for a prolonged time, making the crystal deposits dissolve. </p> <p>Dietary supplements are preparations, such as vitamins, essential minerals, and probiotics. Few studies evaluate their benefits, fewer evaluate their harmful side effects. </p> <p><b>Study characteristics</b> </p> <p>This review is an update of the original review, published in 2014. After searching the medical literature up to August 2020, we found no new studies this time. We kept the two studies from the original review. </p> <p>One study (120 participants) compared enriched skim milk powder (with peptides that are thought to probably have an anti‐inflammatory effect) to standard skim milk, and to lactose powder, to try to reduce the frequency of gout attacks. The second study (40 participants) compared vitamin C with allopurinol <b>–</b> a drug commonly used in gout in an effort to reduce the uric acid levels in blood. Both studies enrolled people with gout who were predominantly middle‐aged men. In the skim milk study, participants appeared to have severe gout, as they had frequent attacks, and 20% to 43% presented with tophi. Participants in the vitamin C study appeared similar to ordinary people with gout. </p> <p><b>Key results – what happens to people with gout who drink enriched skim milk powder?</b> </p> <p><i>Gout attacks</i> </p> <p>People who drank enriched skim milk powder for three months had 0.21 fewer gout attacks per month (from 0.76 fewer to 0.34 more), or 2.5 fewer gout attacks per year: </p> <p>‐ People who drank enriched skim milk powder had 0.49 gout attacks per month (or six gout attacks per year). </p> <p>‐ People who drank standard skim milk powder or lactose had 0.70 gout attacks per month (or eight gout attacks per year). </p> <p><i>Withdrawals due to adverse events</i> </p> <p>Four more people out of 100 who drank enriched skim milk powder discontinued the supplement by three months (4% more withdrawals). </p> <p>‐ 18 out of 100 stopped drinking enriched skim milk powder.</p> <p>‐ 14 out of 100 stopped drinking standard skim milk powder or lactose.</p> <p><i>Number of adverse events</i> </p> <p>People who drank enriched skim milk powder for three months had lesser adverse events (1% lesser adverse events) </p> <p>‐ 47 out of 100 people who drank enriched skim milk powder had an adverse event.</p> <p>‐ 48 out of 100 people who drank standard skim milk powder or lactose had an adverse event. </p> <p>Effects on serum uric acid levels, joint pain, and overall assessment by participants were uncertain. The effect on the disappearance of tophus was not measured. </p> <p><b>Key results – what happens to people with gout who take vitamin C?</b> </p> <p><i>Serum uric acid levels</i> </p> <p>‐ People who took vitamin C showed a reduction in serum uric acid levels of 0.014 mmol/L after eight weeks (or 2.8% reduction) </p> <p>‐ People who took allopurinol showed a reduction in serum uric acid levels of 0.118 mmol/L after eight weeks (or 23.6% reduction). </p> <p>There were no reports of side effects or withdrawals due to side effects in either treatment group. </p> <p>Effects of vitamin C on gout attacks, pain reduction, overall assessment by participants, and tophus disappearance were not measured. </p> <p><b>Quality of the evidence</b> </p> <p>Overall, we found low‐quality evidence in both trials. We reduced the quality of the evidence because the trials were poorly conducted and reported, the sample sizes were small, and the results suggested both benefits and harms for most outcomes. Low‐quality evidence from one study indicated that enriched skim milk, compared with standard skim milk or lactose powder, may not reduce the frequency of gout attacks or improve uric acid levels, but may reduce pain. Further research is likely to change these estimates. We do not have precise information about side effects and complications, but possible side effects may include nausea, bloating or diarrhoea. </p> <p>Compared with the commonly used medicine, allopurinol, low‐quality evidence from one study showed that vitamin C reduced serum uric acid levels less; the difference was probably clinically unimportant. Other possible benefits of vitamin C are uncertain, as they were not evaluated in the study. No side effects were reported. Further research is likely to change these estimates. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010156-sec-0086" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010156-sec-0086"></div> <h3 class="title" id="CD010156-sec-0087">Implications for practice</h3> <section id="CD010156-sec-0087"> <p>The present review found low‐quality evidence that there were no benefits to using vitamin C or glycomacropeptides‐enriched skim milk for people with chronic gout. The literature search did not identify any published intervention studies for other dietary supplements. Findings from this review should be taken into account when considering the prescription of or the advice given regarding dietary supplements for people with chronic gout. </p> <p>While observational studies have reported some effects of dietary supplements in healthy people or in people with asymptomatic hyperuricaemia (such as a lowering of serum uric acid (sUA) with vitamin C), our review found that dietary supplementation is supported by low‐quality evidence for use in people with gout. When compared with the standard urate‐lowering agent, allopurinol, vitamin C, at a dose of 500 mg daily, did not reduce sUA to a significant degree. Whether the addition of glycomacropeptide to skim milk reduces acute gout flares in people with gout, compared to the use of standard skim milk and lactose powder remains uncertain. Further research is likely to change the estimates. </p> </section> <h3 class="title" id="CD010156-sec-0088">Implications for research</h3> <section id="CD010156-sec-0088"> <p>Taking into account the paucity of trials of dietary supplement in gout but their common use in general population, further studies are needed to establish the role of these products in the management of people with gout, despite already having licensed pharmacotherapies proven effective to potentially cure chronic gout (<a href="./references#CD010156-bbs2-0055" title="SethR , KyddAS , BuchbinderR , BombardierC , EdwardsCJ .Allopurinol for chronic gout. Cochrane Database of Systematic Reviews2014, Issue 10. Art. No: CD006077. [DOI: 10.1002/14651858.CD006077.pub3]">Seth 2014</a>). Randomised controlled trials comparing dietary supplements with placebo, no treatment, other supplements, and urate‐lowering medications are needed before any conclusions can be made. However, we acknowledge that short‐term trials may not be the optimal method for assessing the benefits and long‐term sustainability of dietary supplements, and long‐term prospective longitudinal studies or registry data may also be required. </p> <p>We judged the included trials in this review to be at risk of selection, performance and detection bias. Further trials should consider and report their method of randomisation and treatment allocation concealment; blinding of study participants, study personnel and outcome assessment; follow‐up of all participants who entered the trial, and complete reporting of outcomes. Sample sizes should be reported, and have adequate power to answer the research question; ideally, trials should assess both the benefits and risks of dietary supplements. </p> <p>Our review highlights the absence of high‐quality evidence to either support or refute the value of dietary supplementation in people with gout. Though vitamin C appeared suboptimal as a urate‐lowering therapy in comparison with allopurinol, this is derived from low‐quality evidence, so further trials might potentially change this conclusion. In the case of milk powder, a potential anti‐inflammatory effect was noted with milk powder enriched with GMP/G600 (<a href="./references#CD010156-bbs2-0020" title="DalbethN , GraceyE , PoolB , CallonK , McQueenFM , CornishJ , et al.Identification of dairy fractions with anti-inflammatory properties in models of acute gout. Annals of the Rheumatic Diseases2010;69(4):766-9.">Dalbeth 2010</a>). Further trials comparing enriched milk powder with non‐steroidal anti‐inflammatory drugs (NSAIDs) or colchicine in the prevention of acute gout flares may be worthwhile. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010156-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010156-sec-0008"></div> <div class="table" id="CD010156-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Skim milk enriched with GMP/G600 compared with skim milk, plus lactose powder for chronic gout</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Skim milk enriched with GMP/G600 compared with skim milk, plus lactose powder for chronic gout</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with chronic gout </p> <p><b>Settings:</b> outpatients, community </p> <p><b>Intervention:</b> skim milk enriched with glycomacropeptides (GMP)/G600 </p> <p><b>Comparison:</b> skim milk or lactose powder (data from 2 groups combined) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Skim milk and lactose powder</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Skim milk enriched with GMP/G600</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Acute gout flares</b><br/>Participant self‐report, using gout flare diary<br/>Follow‐up: 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean acute gout attack frequency in the control groups was<br/><b>0.70 gout flares per month</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean acute gout attack frequency in the intervention group was <b>0.21 flares per month lower</b><br/>(0.76 lower to 0.34 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120<br/>(1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute effect 21% lower (76% lower to 34% higher)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study withdrawals due to adverse events</b> </p> <p>Follow‐up: 3 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>138 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>175 per 1000</b><br/>(73 to 417) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.27</b> <br/>(0.53 to 3.03) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120<br/>(1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk difference: 4% more withdrawals (10% fewer to 18% more).</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>sUA acid reduction</b><sup>b</sup> </p> <p>(in mmol/L)</p> <p>Follow‐up: 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean sUA level reduction in the control groups was ‐<b>0.010 mmol/L</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean sUA level reduction in the intervention group was <b>0.01 mmol/L lower</b> </p> <p>(0.04 lower to 0.01 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute reduction 0.01 mmol/L (0.04 lower to 0.01 higher)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Joint pain reduction</b><br/>10‐point Likert scale (0 = no pain)<br/>Follow‐up: 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean joint pain reduction in the control groups was <b>‐0.94 points</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean joint pain reduction in the intervention group was <b>1.03 points lower</b><br/>(1.9 lower to 0.1 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120<br/>(1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk difference: 10% lower (1% lower to 20% lower).</p> <p>NNTB = 10 (5 to 100)<sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant global assessment</b> </p> <p>5‐point Likert scale (5 = excellent)</p> <p>Follow‐up: 3 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Measured and reported in text as improved similarly between groups, but unable to obtain data </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total adverse events</b><sup>d</sup> </p> <p>Follow‐up: 3 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>487 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>472 per 1000</b><br/>(321 to 706) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.97</b> (0.66 to 1.45) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120<br/>(1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk difference: 1% less adverse events (1% fewer to 2% more).</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Tophus regression</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>HAQ:</b> Health Assessment Questionnaire; <b>RR:</b> risk ratio; <b>sUA:</b> serum uric acid. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>There was a possible influence of selection and detection bias. In addition, the imprecision of the results (in relation to the small size study) contributed to downgrading the quality of the results. Selective reporting of post hoc comparisons between skim milk powder enriched with GMP/G600 and one of the two study controls (lactose) in relation to change in gout attack frequency from baseline were noted, but it was controlled after the raw data were provided by the study authors.<br/><sup>b</sup>Data regarding sUA normalisation not reported.<br/><sup>c</sup>Number needed to treat for an additional beneficial outcome (NNTB) for continuous outcomes calculated using the Wells calculator software available from the Cochrane Musculoskeletal Group editorial office.<br/><sup>d</sup>Gastrointestinal adverse events (diarrhoea, nausea and flatulence) reported most commonly. There were no serious adverse events that resulted in hospital admissions due to the study products. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD010156-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Vitamin C compared with allopurinol for chronic gout</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Vitamin C compared with allopurinol for chronic gout</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> peoeple with chronic gout and sUA level &gt; 0.36 mmol/L </p> <p><b>Settings:</b> outpatients, rheumatology clinics </p> <p><b>Intervention:</b> vitamin C </p> <p><b>Comparison:</b> allopurinol </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Allopurinol</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Vitamin C</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Acute gout flares</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study withdrawals due to adverse events</b> </p> <p>Follow‐up: 8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>sUA reduction</b> </p> <p>Follow‐up: 8 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean sUA reduction in the control group was <b>0.118 mmol/L</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean sUA reduction in the intervention group was <b>0.10 mmol/L</b> less reduction (0.06 to 0.15) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute difference: 10% higher (6% higher to 15% higher)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Joint pain reduction</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant global assessment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total adverse events</b> </p> <p>Follow‐up: 8 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>None reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>None reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None reported. No participants developed oxalate renal stones or oxalosis</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Tophus regression</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>sUA:</b> serum uric acid. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Potential selection, performance, and detection bias might influence the results, as it is an open trial; downgraded twice for bias. No imprecision in data reporting was noted. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010156-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010156-sec-0009"></div> <section id="CD010156-sec-0010"> <h3 class="title" id="CD010156-sec-0010">Description of the condition</h3> <p>Gout is a musculoskeletal disease characterised by recurrent episodes of acute arthritis, which are due to deposition of monosodium urate (MSU) crystals in the joints. It affects up to 1% to 2% of adults, and is the most common inflammatory arthritis in men (<a href="./references#CD010156-bbs2-0056" title="SmithEU , Diaz-TorneC , Perez-RuizF , MarchLM .Epidemiology of gout: an update. Best Practice and Research Clinical Rheumatology2010;24(6):811-27.">Smith 2010</a>). Persistent hyperuricaemia leads to the deposition of MSU crystals in the synovial lining, tendons, ligaments, and other body sites. Most people with gout have recurrent bouts of acute arthritis, with the first metatarsophalangeal joint of the foot being the most frequently affected joint. Attacks usually resolve spontaneously within one week, and the condition is asymptomatic between episodes, although persistent subclinical inflammation has been noted in the synovial fluid from asymptomatic joints (<a href="./references#CD010156-bbs2-0039" title="PascualE , Batlle-GualdaE , MartínezA , RosasJ , VelaP .Synovial fluid analysis for diagnosis of intercritical gout. Annals of Internal Medicine1999;131(10):756-9.">Pascual 1999</a>). People with longstanding disease may develop persistent arthritis, leading to joint damage and disability. Other clinical consequences of crystal deposition are the development of focal crystal nodes, known as tophi (<a href="./references#CD010156-bbs2-0047" title="RichetteP , BardinT .Gout. Lancet2010;375(9711):318-28.">Richette 2010</a>). Tophi are usually found in limb extension surfaces and pressure areas, but they can appear anywhere. In addition, people with gout are at high risk of developing urate renal stones, and a form of kidney damage (urate nephropathy) has been related to the deposit of crystals in the interstitium and medulla; the significance of this condition is unclear (<a href="./references#CD010156-bbs2-0037" title="NickeleitV , MihatschMJ .Uric acid nephropathy and end-stage renal disease – review of a non-disease. Nephrology Dialysis Transplantation1997;12:1832-8.">Nickeleit 1997</a>). On top of these consequences of the crystal deposits, gout is strongly associated with an increased cardiovascular risk (<a href="./references#CD010156-bbs2-0029" title="KrishnanE , SvendsenK , NeatonJD , GranditsG , KullerLH , MRFIT Research Group.Long-term cardiovascular mortality among middle-aged men with gout. Archives of Internal Medicine2008;168(10):1104-10.">Krishnan 2008</a>; <a href="./references#CD010156-bbs2-0030" title="KuoCF , SeeLC , LuoSF , KoYS , LinYS , HwangJS , et al.Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatology (Oxford)2010;49(1):141-6.">Kuo 2010</a>). </p> <p>To prevent further acute attacks of gout and ongoing subclinical inflammation, the aim of treatment in gout is to reduce serum uric acid (sUA) levels, which ultimately leads to dissolution of crystals in the joints, and reduction in size and eventual disappearance of tophi (<a href="./references#CD010156-bbs2-0040" title="PascualE , SiveraF .Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout. Annals of the Rheumatic Diseases2007;66(8):1056-8.">Pascual 2007</a>; <a href="./references#CD010156-bbs2-0043" title="Perez-RuizF , CalabozoM , PijoanJI , Herrero-BeitesAM , RuibalA .Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis and Rheumatism2002;47(4):356-60.">Perez‐Ruiz 2002</a>). To achieve the best outcomes, experts recommend reaching and maintaining sUA levels below 0.33 mmol/L for most people, and considering stricter thresholds (0.27mmol/L) for people with severe cases (<a href="./references#CD010156-bbs2-0048" title="RichetteP , DohertyM , PascualE , BarskovaV , BecceF , Castañeda-SanabriaJ , et al.2016 updated EULAR evidence-based recommendations for the management of gout. Annals of the Rheumatic Diseases2017;76(1):29-42. [DOI: 10.1136/annrheumdis-2016-209707]">Richette 2017</a>). When MSU crystals are absent from joints and tissues, gout can be considered to be cured (<a href="./references#CD010156-bbs2-0041" title="PascualE , SiveraF .Gout: new advances on diagnosis and management of an old disease. International Journal of Clinical Rheumatology2009;4:203-20.">Pascual 2009a</a>). The present review will restrict the assessment to populations with chronic gout; this term, currently not recommended by international experts (<a href="./references#CD010156-bbs2-0016" title="BursillD , TaylorWJ , TerkeltaubR , KuwabaraM , MerrimanTR , GraingerR , et al.Gout, Hyperuricemia, and Crystal-Associated Disease Network consensus statement regarding Labels and definitions for disease elements in gout. Arthritis Care &amp; Research2019;71(3):427‐34. [DOI: 10.1002/acr.23607]">Bursill 2019</a>), is intended to cover the disease stage between flares (acute gout), when management is focused on flare prevention and crystal dissolution by normalising sUA levels. </p> <p>Several drugs have been used since the mid‐1980s to lower sUA levels by two mechanisms of action: 1. reduce uric acid synthesis by blocking xanthine oxidase (<a href="./references#CD010156-bbs2-0027" title="KlinenbergJR , GoldfingerSE , SeegmillerJE .The effectiveness of the xanthine oxidase inhibitor allopurinol in the treatment of gout. Annals of Internal Medicine1965;62:639-47.">Klinenberg 1965</a>; <a href="./references#CD010156-bbs2-0042" title="PascualE , SiveraF , YasothanU , KirkpatrickP .Febuxostat. Nature Reviews Drug Discovery2009;8(3):191-2.">Pascual 2009b</a>), as is the case with allopurinol and febuxostat, and 2. increase renal uric acid excretion through the inhibition of its re‐absorption at the proximal convoluted tubules of the kidney (<a href="./references#CD010156-bbs2-0047" title="RichetteP , BardinT .Gout. Lancet2010;375(9711):318-28.">Richette 2010</a>), as is the case with benzbromarone, sulphinpyrazone, and probenecid. Recombinant uricases, such as pegloticase that convert uric acid into allantoin, have also been approved for refractory cases (<a href="./references#CD010156-bbs2-0032" title="Lyseng-WilliamsonKA .Pegloticase: in treatment-refractory chronic gout. Drugs2011;71(16):2179-92.">Lyseng‐Williamson 2011</a>). Besides pharmacological therapy to reduce sUA, lifestyle changes (e.g. weight loss, exercise, and diet modifications) might also have a role in the management of people with gout, though evidence is lacking to establish the exact impact of this approach in people with gout. </p> </section> <section id="CD010156-sec-0011"> <h3 class="title" id="CD010156-sec-0011">Description of the intervention</h3> <p>Dietary supplements are widely used by the general population to prevent and treat many diseases and conditions (<a href="./references#CD010156-bbs2-0063" title="WuCH , WangCC , KennedyJ .Changes in herb and dietary supplement use in the U.S. adult population: a comparison of the 2002 and 2007 National Health Interview Surveys. Clinical Therapeutics2011;33(11):1749-58.">Wu 2011</a>). These are usually obtained over the counter, rather than being prescribed by doctors. There are different types of dietary supplements, including amino acids (e.g. carnitine, glutamine), antioxidant agents (e.g. melatonin, acetylcysteine), essential minerals (e.g. selenium, calcium, phosphorus), polyunsaturated fatty acids (PUFA), probiotics (e.g. lactobacillus, bifidobacterium), vitamins (e.g. vitamin C, vitamin E, folic acid), and many more. People with rheumatic diseases, such as osteoarthritis or inflammatory arthritis, often use dietary supplements (<a href="./references#CD010156-bbs2-0015" title="BuchbinderR , GingoldM , HallS , CohenM .Non-prescription complementary treatments used by rheumatoid arthritis patients attending a community-based rheumatology practice. Internal Medicine Journal2002;32:208-14.">Buchbinder 2002</a>; <a href="./references#CD010156-bbs2-0061" title="VistaES , LauCS .What about supplements for osteoarthritis? A critical and evidence-based review. International Journal of Rheumatic Diseases2011;14(2):152-8.">Vista 2011</a>); people with other chronic musculoskeletal conditions are also reported to be frequent users of homeopathic and complementary medicines (<a href="./references#CD010156-bbs2-0051" title="RossignolM , BégaudB , AvouacB , LertF , RouillonF , BénichouJ , et al.Who seeks primary care for musculoskeletal disorders (MSDs) with physicians prescribing homeopathic and other complementary medicine? Results from the EPI3-LASER survey in France. BMC Musculoskeletal Disorders2011;12:21.">Rossignol 2011</a>). Despite the uncertainty from published studies, it is likely that people with gout also take supplements among other remedies. A quick search on Google with 'uric acid how to reduce' shows more than four million hits, most of which come from non‐medical resources. </p> <p>However, dietary supplements might be associated with potential adverse effects. Cases of increased bleeding risk related to different herbs and herbal formulae (<a href="./references#CD010156-bbs2-0062" title="WongWW , GabrielA , MaxwellGP , GuptaSC .Bleeding risks of herbal, homeopathic, and dietary supplements: a hidden nightmare for plastic surgeons?Aesthetic Surgery Journal2012;32(3):332-46.">Wong 2012</a>), liver injury due to camellia sinensis tea extracts or usnic acid (<a href="./references#CD010156-bbs2-0059" title="StickelF , KessebohmK , WeimannR , SeitzHK .Review of liver injury associated with dietary supplements. Liver International2011;31(5):595-605.">Stickel 2011</a>), or cardiac dysrhythmias due to enzyte (<a href="./references#CD010156-bbs2-0045" title="PhilipsM , SullivanB , SnyderB , AllegrettiPJ , McBrideBF .Effect of enzyte on QT and QTc intervals. Archives of Internal Medicine2010;170(15):1402-4.">Philips 2010</a>), have been reported. Taking into account the increasing use of dietary supplements, mostly with no medical prescription, these should be considered as potentially harmful. </p> </section> <section id="CD010156-sec-0012"> <h3 class="title" id="CD010156-sec-0012">How the intervention might work</h3> <p>There is minimal evidence of how these supplements might work in gout; some might reduce sUA levels or have an anti‐inflammatory effect, but other unidentified mechanisms are possible. Evidence suggests that diet supplements, such as vitamin C (<a href="./references#CD010156-bbs2-0026" title="JuraschekSP , Miller ER 3rd, GelberAC .Effect of oral vitamin C supplementation on serum uric acid: a meta-analysis of randomized controlled trials. Arthritis Care &amp; Research2011;63(9):1295-306.">Juraschek 2011</a>), depurinised milk (<a href="./references#CD010156-bbs2-0028" title="KocicG , PavlovicR , NikolicG , StojanovicD , JevtovicT , SokolovicD , et al.The effect of depurinized milk draught diet on rat serum uric acid, lipid status and haematological parameters. Journal of Animal Physiology and Animal Nutrition2012;96:648-55.">Kocic 2012</a>), and casein or soy proteins (<a href="./references#CD010156-bbs2-0031" title="LoHC , WangYH , ChiouHY , LaiSH , YangY .Relative efficacy of casein or soya protein combined with palm or safflower-seed oil on hyperuricaemia in rats. British Journal of Nutrition2010;104(1):67-75.">Lo 2010</a>), have sUA‐lowering effects. However, most of these studies have been conducted in animals, or in humans without gout. Diet supplements may also have beneficial effects on inflammation or pain, such as vitamin D (<a href="./references#CD010156-bbs2-0066" title="ZhangY , LeungDY , RichersBN , LiuY , RemigioLK , RichesDW , et al.Vitamin D inhibits monocyte/macrophage pro-inflammatory cytokine production by targeting MAPK phosphatase-1. Journal of Immunology2012;188(5):2127-35.">Zhang 2012</a>), omega‐3 fatty acid supplements (<a href="./references#CD010156-bbs2-0036" title="MoriTA , WoodmanRJ .The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Current Opinion in Clinical Nutrition and Metabolic Care2006;9(2):95-104.">Mori 2006</a>), or avocado‐soybean unsaponifiables (<a href="./references#CD010156-bbs2-0018" title="ChristensenR , BartelsEM , AstrupA , BliddalH .Symptomatic efficacy of avocado-soybean unsaponifiables (ASU) in osteoarthritis (OA) patients: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage2008;16(4):399-408.">Christensen 2008</a>). </p> </section> <section id="CD010156-sec-0013"> <h3 class="title" id="CD010156-sec-0013">Why it is important to do this review</h3> <p>Due to the significant population's belief in dietary supplements for the treatment of arthritis, including gout, it is important to assess current evidence that examines these interventions. This would provide clinicians with useful information in order to optimise advice to people with gout. We completed an initial review published in 2014 (<a href="./references#CD010156-bbs2-0067" title="AndrésM , SiveraF , FalzonL , BuchbinderR , CarmonaL .Dietary supplements for chronic gout. Cochrane Database of Systematic Reviews2014, Issue 10. Art. No: CD010156. [DOI: 10.1002/14651858.CD010156.pub2]">Andres 2014</a>). We only identified data for glycomacropeptides and vitamin C, and found an unclear benefit for people with gout. We updated the search to August 2020 in this update, in order to cover potential new studies on the topic. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010156-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010156-sec-0014"></div> <p>To assess the benefits and safety of dietary supplements for the treatment of chronic gout. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010156-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010156-sec-0015"></div> <section id="CD010156-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010156-sec-0017"> <h4 class="title">Types of studies</h4> <p>We considered all published randomised controlled trials (RCTs) or quasi‐RCTs (clinical controlled trials (CCTs)) that compared dietary supplements with no supplements, placebo, another supplement, or pharmacological agents for chronic gout. As we were primarily interested in the use of dietary supplements to prevent further acute attacks of gout, and reduce levels of serum uric acids (sUA), we excluded trials in acute gout, where the aims of treatment were different, namely to reduce acute inflammation. </p> <p>We only included trials that were published as full articles, or available as a full trial report. </p> </section> <section id="CD010156-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included adults (aged 18 years or older) with a diagnosis of chronic gout. We excluded studies that incorporated a mix of people with gout and other musculoskeletal diseases, unless we could separate results for the gout population for analysis. </p> </section> <section id="CD010156-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We included all trials that evaluated any dietary supplement, including, but not limited to, amino acids, antioxidants, polyunsaturated fatty acids (PUFA), prebiotic agents, probiotic agents, or vitamins, alone or in combination. We examined all doses and routes of administration. </p> <p>Comparators could have been:</p> <p> <ol id="CD010156-list-0001"> <li> <p>placebo;</p> </li> <li> <p>no treatment;</p> </li> <li> <p>a different dietary supplement;</p> </li> <li> <p>standard of care (allopurinol);</p> </li> <li> <p>non‐pharmacological therapy (e.g. diet modification);</p> </li> <li> <p>combination therapy (any of the above in combination).</p> </li> </ol> </p> </section> <section id="CD010156-sec-0020"> <h4 class="title">Types of outcome measures</h4> <p>OMERACT (Outcome Measures in Rheumatology) is an international network, interested in outcome measurement across the spectrum of rheumatology intervention studies (<a href="./references#CD010156-bbs2-0060" title="TugwellP , BoersM .OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction. Journal of Rheumatology1993;20(3):528-30.">Tugwell 1993</a>). At the OMERACT‐9 conference, the core and discretionary domains for outcome measurement in clinical studies of acute and chronic gout were defined (<a href="./references#CD010156-bbs2-0052" title="SchumacherHR , TaylorW , EdwardsL , GraingerR , SchlesingerN , DalbethN , et al.Outcome domains for studies of acute and chronic gout. Journal of Rheumatology2009;36(10):2342-5.">Schumacher 2009</a>). For acute gout, core domains included pain, joint swelling, joint tenderness, participant global assessment, and activity limitations. For chronic gout, core domains included sUA, acute gout attacks, tophus burden, health‐related quality of life, activity limitation, pain, and participant global assessment. </p> <p>We included only outcome core domains for chronic gout, plus safety in this review. For the purpose of this review, if feasible, we grouped trials into those of short‐term (less than three months), medium‐term (three to 12 months) and long‐term (greater than 12 months) duration. </p> <section id="CD010156-sec-0021"> <h5 class="title">Major outcomes</h5> <p> <ol id="CD010156-list-0002"> <li> <p>Acute gout flares</p> </li> <li> <p>Study withdrawals due to adverse events (AE)</p> </li> <li> <p>sUA reduction</p> </li> <li> <p>Joint pain reduction</p> </li> <li> <p>Participant global assessment</p> </li> <li> <p>Total adverse events</p> </li> <li> <p>Tophus regression</p> </li> </ol> </p> </section> <section id="CD010156-sec-0022"> <h5 class="title">Minor outcomes</h5> <p> <ol id="CD010156-list-0003"> <li> <p>Physical function (or disability)</p> </li> <li> <p>Serious AEs</p> </li> </ol> </p> </section> </section> </section> <section id="CD010156-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010156-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We searched a registry of all RCTs in gout, established by Cochrane Musculoskeletal to facilitate the updates of a series of reviews of interventions for gout, including this review update. The search for the gout registry was designed to not include terms for any interventions, in order to establish a registry of all randomised trials in this condition, regardless of the intervention. </p> <p>The following electronic databases were searched to establish the registry. The search strategy combined standard Cochrane search filters for 'gout' and 'randomised trial', with no language restrictions. </p> <p> <ol id="CD010156-list-0004"> <li> <p>The Cochrane Central Register of Controlled Trials (CENTRAL; 2020, Issue 10) in the Cochrane Library (searched 28 August 2020; <a href="./appendices#CD010156-sec-0092">Appendix 1</a>); </p> </li> <li> <p>MEDLINE Ovid (1950 to 28 August 2020; <a href="./appendices#CD010156-sec-0093">Appendix 2</a>); </p> </li> <li> <p>Embase (1980 to 28 August 2020; <a href="./appendices#CD010156-sec-0094">Appendix 3</a>); </p> </li> <li> <p>CINAHL (Cumulative Index to Nursing and Allied Health Literature; 1937 to August 2020; <a href="./appendices#CD010156-sec-0095">Appendix 4</a>); </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>; searched 27 August 2020); </p> </li> <li> <p>Australian &amp; New Zealand Clinical Trial Registry (<a href="http://www.anzctr.org.au" target="_blank">www.anzctr.org.au</a>; searched 27 August 2020); </p> </li> <li> <p>Chinese Clinical Trial Registry (<a href="http://www.chictr.org.cn/enindex.aspx" target="_blank">http://www.chictr.org.cn/enindex.aspx</a>; searched 27 August 2020); </p> </li> <li> <p>World Health Organization (WHO) Clinical Trials Registry Platform (<a href="http://www.who.int/ictrp/en/" target="_blank">www.who.int/ictrp/en/</a>; searched 27 August 2020). </p> </li> </ol> </p> <p>We searched the CINAHL database because data regarding dietary supplements might be published in non‐medical journals that were not indexed by the other databases. Details of the search strategies used for the previous version of the review are given in <a href="./references#CD010156-bbs2-0067" title="AndrésM , SiveraF , FalzonL , BuchbinderR , CarmonaL .Dietary supplements for chronic gout. Cochrane Database of Systematic Reviews2014, Issue 10. Art. No: CD010156. [DOI: 10.1002/14651858.CD010156.pub2]">Andres 2014</a>. </p> </section> <section id="CD010156-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We hand‐searched the abstracts from the two major international rheumatology scientific meetings, the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR), from 2010 to 2019. </p> </section> </section> <section id="CD010156-sec-0026"> <h3 class="title" id="CD010156-sec-0026">Data collection and analysis</h3> <section id="CD010156-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Editorial staff from Cochrane Musculoskeletal initially screen titles and abstracts in the gout registry and retrieve the full text for all records they identifiy as RCTs of an intervention for people with gout. They annotate the population, intervention, and comparator for each full‐text article, and assign it to the appropriate gout review. </p> <p>We downloaded the full search to a reference management library (Endnote® X5.0.1, PDFTron, 2010) and eliminated duplicates. Two review authors (MA, FS) independently selected the studies for detailed review and collected the data, including items to assess risk of bias, of the finally included studies. We resolved any disagreements by discussion with a third review author (LC). </p> <p>Two review authors (MA, FS) independently assessed the titles and abstracts of all identified registers to identify the trials that fulfilled selection criteria. We retrieved all possibly relevant articles, including those with a related title and without an abstract, in full text. We resolved any disagreements in study selection by consensus or by discussion with a third review author if needed. We translated studies into English where necessary. We identified and excluded duplicates and recorded the selection process in sufficient detail to complete a Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) flow diagram and the 'Characteristics of excluded studies' table (<a href="./references#CD010156-bbs2-0034" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , The PRISMA Group.Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ2009;339:b2535. [DOI: 10.1136/bmj.b2535]">Moher 2009</a>). </p> </section> <section id="CD010156-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>We prepared pre‐piloted forms in advance to help collect the relevant data. Two review authors (MA, FS) independently extracted relevant information from the included trials, extracting study design, characteristics of study population, treatment regimen and duration, outcomes, and timing of outcome assessment. </p> <p>Two review authors (MA, FS) independently extracted outcome data from included studies. We extracted the number of events and number of participants per treatment group for dichotomous outcomes, and means and standard deviations and number of participants per treatment group for continuous outcomes. We noted in the 'Characteristics of included studies' table if outcome data were not reported in a usable way, and when data were transformed or estimated from a graph. We resolved disagreements by consensus or by involving a third person (LC). One review author (MA) transferred data into the Review Manager 5 file (<a href="./references#CD010156-bbs2-0046" title="Review Manager 5 (RevMan 5).Version 5.4.1. The Cochrane Collaboration, 2020.">Review Manager 2020</a>). We double‐checked that data were entered correctly by comparing the data presented in the systematic review with the study reports. </p> </section> <section id="CD010156-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (MA, FS) independently assessed the potential for bias using Cochrane's RoB 1 tool for assessing risk of bias (<a href="./references#CD010156-bbs2-0023" title="HigginsJP , AltmanDG , SterneJA , editor(s).Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). This included assessing the potential for bias in the following domains: </p> <p> <ol id="CD010156-list-0005"> <li> <p>Random sequence generation</p> </li> <li> <p>Allocation concealment</p> </li> <li> <p>Blinding of participants and personnel</p> </li> <li> <p>Blinding of outcome assessment</p> </li> <li> <p>Incomplete outcome data</p> </li> <li> <p>Selective outcome reporting</p> </li> <li> <p>Other bias</p> </li> </ol> </p> <p>We judged each of these domains as low risk of bias, high risk of bias, or unclear risk of bias (either lack of adequate information or uncertainty over the potential for bias). We resolved disagreements by consensus; a third review author (LC) acted as arbiter. When considering treatment effects, we took into account the risk of bias for the studies that contributed to that outcome. We presented the figures generated by RoB 1 to provide summary assessments of the risk of bias. </p> </section> <section id="CD010156-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>We used Cochrane's statistical software, Review Manager 5, to analyse data (<a href="./references#CD010156-bbs2-0046" title="Review Manager 5 (RevMan 5).Version 5.4.1. The Cochrane Collaboration, 2020.">Review Manager 2020</a>). We planned to perform meta‐analyses only if the data of the included studies were sufficiently clinically homogeneous. We presented the results of dichotomous data as risk ratios (RRs) with the corresponding 95% confidence intervals (CIs). We presented the results of continuous variables as mean differences (MDs) between the intervention and comparator groups with the corresponding 95% CIs. When different scales were used to measure the same conceptual domain, we calculated standardised mean differences (SMDs) with the corresponding 95% CIs instead. For the calculation of SMD, we divided the MD by the SD, resulting in a measure without units of treatment effect. SMDs larger than zero indicated a beneficial effect of the dietary supplementation. As described in <a href="./references#CD010156-bbs2-0019" title="CohenJ .Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.">Cohen 1988</a>, an SMD of 0.2 indicated a small beneficial effect, 0.5 a medium effect, and 0.8 a large effect in favour of dietary supplementation. We considered a SMD to be clinically relevant if it was greater than 0.5. SMD was translated back into the original units of the particular instrument, in order to facilitate appraisal by clinicians. We considered the results of count data (such as the number of gout flares) as continuous outcome data if events were common, and as RRs if they were rare events (<a href="./references#CD010156-bbs2-0024" title="HigginsJPT , LiT , DeeksJJ , editor(s).Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.">Higgins 2021a</a>). </p> <p>For dichotomous outcomes, the number needed‐to‐treat for an additional beneficial outcome (NNTB), or the number needed to treat for an additional harmful outcome (NNTH) was calculated from the control group event rate and the relative risk using the Visual Rx NNT calculator (<a href="./references#CD010156-bbs2-0017" title="CatesC .Visual Rx Version 3. www.nntonline.net/visualrx/ (accessed 10 September 2014).">Cates 2008</a>). For dichotomous outcomes, we calculated the absolute percent change from the difference in the risks between the intervention and control group using GRADEpro, and expressed as a percentage (<a href="./references#CD010156-bbs2-0022" title="GRADEpro GDT.Version accessed prior to 13 December 2020. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT 2015</a>). For continuous outcomes, we calculated the absolute percent change by dividing the mean difference by the scale of the measure, and expressing it as a percentage. In the Effects of interventions section, and the What happens column of the summary of findings table, we provided the absolute percent change and the NNTB or NNTH (the NNTB or NNTH provided only when the outcome showed a clinically significant difference). </p> </section> <section id="CD010156-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>For studies containing more than two intervention groups, making multiple pair‐wise comparisons between all possible pairs of intervention groups possible, we planned to include the same group of participants only once in the meta‐analysis. In the event that we had identified cross‐over trials, in which the reporting of continuous outcome data precluded paired analysis, we planned to include these data in a meta‐analysis, in order to avoid unit of analysis error. When we thought carry‐over effects existed, and when sufficient data existed, we intended to only include data from the first period in the analysis. When outcomes were collected at multiple follow‐up times (within the short‐term, medium‐term, and long‐term time frames), we extracted the last outcome. </p> </section> <section id="CD010156-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>When data were missing or incomplete, we contacted study authors for further information.</p> <p>In cases where individual data were missing from the reported results, and no further information was forthcoming from the study authors, we assumed the missing values to have a poor outcome. For dichotomous variables that measured AEs, we calculated the withdrawal rate using the number of participants who received treatment as the denominator (worst‐case analysis). For dichotomous outcomes that measured benefits, we calculated the worst‐case analysis using the number of randomised individuals as the denominator. For continuous variables, we calculated the MD or the SMD, based on the number of participants analysed at the time point. If the number of participants analysed was not available, we would have used the number of randomised participants in each group at baseline. </p> <p>Where possible, we planned to calculate missing SDs from other statistics, such as standard errors, CI, or P values, according to the methods recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010156-bbs2-0021" title="DeeksJJ , HigginsJPT , AltmanDG , editor(s).Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.">Deeks 2021</a>). If we could not calculate missing SDs, and there were very few missing, we planned to impute them from other studies in the meta‐analysis. </p> </section> <section id="CD010156-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We planned to assess both clinical and statistical heterogeneity between studies. First, we planned to assess studies for clinical homogeneity with respect to study participants, intervention groups, outcome measures, and timing of outcome. For studies judged as clinically similar, we assessed statistical heterogeneity using the I² statistic (<a href="./references#CD010156-bbs2-0021" title="DeeksJJ , HigginsJPT , AltmanDG , editor(s).Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.">Deeks 2021</a>). We used the following approximate thresholds for the interpretation of I²: 0% to 40% heterogeneity might not be important; 30% to 60% represented moderate heterogeneity; 50% to 90% represented substantial heterogeneity; and greater than 75% represented considerable heterogeneity. In cases of substantial heterogeneity, we planned to explore the data further, including subgroup analyses, to explain the heterogeneity. </p> </section> <section id="CD010156-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>To assess whether reporting bias was present, we determined whether the protocols of included trials were published before recruitment of participants began. For trials published after 1 July 2005, we searched the WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>). </p> <p>We planned to evaluate whether selective reporting of outcomes was present.</p> <p>We planned to compare the fixed‐effect estimate against the random‐effects model to assess the possible presence of small sample bias in the published literature (i.e. in which the intervention effect was more beneficial in smaller studies). In the presence of small sample bias, the random‐effects estimate of the intervention is more beneficial than the fixed‐effect estimate (<a href="./references#CD010156-bbs2-0038" title="PageMJ , HigginsJPT , SterneJAC .Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.">Page 2021</a>). </p> <p>We planned to explore the potential for reporting bias using funnel plots if at least 10 studies were available for meta‐analysis. </p> </section> <section id="CD010156-sec-0035"> <h4 class="title">Data synthesis</h4> <p>We presented the characteristics of included studies in the <a href="./references#CD010156-sec-0105" title="">Characteristics of included studies</a> table, results from the search and selection of studies in a flowchart, risk of bias in a figure, and specific results by type of study, and by outcome. If we considered studies sufficiently homogeneous, we planned to pool data in a meta‐analysis using a random‐effects model, regardless of the I² statistic results. We planned to perform analyses using Review Manager 5, and produce forest plots for all analyses (<a href="./references#CD010156-bbs2-0046" title="Review Manager 5 (RevMan 5).Version 5.4.1. The Cochrane Collaboration, 2020.">Review Manager 2020</a>). </p> </section> <section id="CD010156-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>In order to explore the heterogeneity of the included studies, we planned a subgroup analysis (if sufficient data were available) for the effect of gender, as different levels of sUA have been reported in men and women (<a href="./references#CD010156-bbs2-0057" title="StampLK , ZhuX , DalbethN , JordanS , EdwardsNL , TaylorW .Serum urate as a soluble biomarker in chronic gout-evidence that serum urate fulfils the OMERACT validation criteria for soluble biomarkers. Seminars in Arthritis and Rheumatism2011;40(6):483-500.">Stamp 2011</a>). Ideally, we would extract the main outcomes separately for men and women from each trial. </p> <p>We planned to use the formal test for subgroup interactions in Review Manager 5, and cautiously interpret the subgroup analyses, as advised in chapter 10 of the <i>Cochrane Handbook</i> (<a href="./references#CD010156-bbs2-0021" title="DeeksJJ , HigginsJPT , AltmanDG , editor(s).Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.">Deeks 2021</a>). We planned to compare the effect sizes in the subgroup analyses informally to assess possible differences in response to treatment, by considering the overlap of the CIs of the summary estimates in the two subgroups <b>–</b> non‐overlap of the CIs indicated statistical significance. As we had anticipated, the outcomes were not reported by gender in the trials, precluding this planned analysis. </p> <p>However, one trial did report data by whether or not participants were allopurinol naive, and we reported this subgroup analysis. </p> </section> <section id="CD010156-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>Where sufficient studies existed, we planned sensitivity analyses to assess the impact of including data in a meta‐analysis from trials that were susceptible to selection bias (i.e. with inadequate or unclear allocation concealment), and trials that were susceptible to detection bias (i.e. with inadequate or unclear outcome assessment blinding). However, as there were only two included studies and pooling was not possible, we did not perform sensitivity analyses. </p> <section id="CD010156-sec-0038"> <h5 class="title">Interpreting results and reaching conclusions</h5> <p>We followed the guidelines in the <i>Cochrane Handbook for Systematic Reviews of Intervention</i>s, chapter 15, for interpreting results, and were careful to distinguish a lack of evidence of effect from a lack of effect (<a href="./references#CD010156-bbs2-0054" title="SchünemannHJ , VistGE , HigginsJPT , SantessoN , DeeksJJ , GlasziouP , et al.Chapter 15: Interpreting results and drawing conclusions. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.">Schünemann 2021a</a>). We based our conclusions only on findings from the quantitative or narrative synthesis of included studies. We avoided making recommendations for practice. Our implications for research suggest priorities for future research, and outline the remaining uncertainties in the area. </p> </section> </section> <section id="CD010156-sec-0039"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We presented key findings using summary of findings tables. These tables provide key information about the quality, or certainty of the evidence, the effect size of the interventions examined, and the available data on the outcomes (<a href="./references#CD010156-bbs2-0053" title="SchünemannHJ , HigginsJPT , VistGE , GlasziouP , AklEA , SkoetzN , et al.Chapter 14: Completing ‘Summary of findings’ tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.">Schünemann 2021</a>). They include an overall grade of the evidence related to each of the main outcomes using the GRADE approach (<a href="./references#CD010156-bbs2-0022" title="GRADEpro GDT.Version accessed prior to 13 December 2020. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT 2015</a>). For the summary of findings table, we included the seven major outcomes: </p> <p> <ul id="CD010156-list-0006"> <li> <p>acute gout flares;</p> </li> <li> <p>study withdrawals due to serious adverse events (AEs);</p> </li> <li> <p>sUA reduction;</p> </li> <li> <p>joint pain reduction;</p> </li> <li> <p>participant global assessment;</p> </li> <li> <p>total number of AEs; and</p> </li> <li> <p>tophus regression.</p> </li> </ul> </p> <p>Two people (MA, FS) independently assessed the certainty of the evidence. We used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness, and publication bias) to assess the certainty of the body of evidence as it related to the studies that contributed data for the prespecified outcomes, and reported the certainty of evidence as high, moderate, low, or very low. We used methods and recommendations described in Chapter 14 of the <i>Cochrane Handbook for Systematic Reviews of Interventions (</i><a href="./references#CD010156-bbs2-0053" title="SchünemannHJ , HigginsJPT , VistGE , GlasziouP , AklEA , SkoetzN , et al.Chapter 14: Completing ‘Summary of findings’ tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.">Schünemann 2021</a>). We used GRADEpro GDT software to prepare the summary of findings tables (<a href="./references#CD010156-bbs2-0022" title="GRADEpro GDT.Version accessed prior to 13 December 2020. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT 2015</a>). We justified all decisions to downgrade the certainty of evidence for each outcome in footnotes, and made comments to aid the reader's understanding of the review where necessary. We provided the absolute and relative per cent change, and the number needed to treat for an additional beneficial or harmful outcome in the What happens column of the summary of findings table, as described in the <a href="https://archie.cochrane.org/sections/documents/view?version=z1903121012351062420926670709362&amp;format=REVMAN#EFFECT_MEASURES" target="_blank">Measures of treatment effect</a> section above, with the exception of the absolute difference for dichotomous outcomes, which is displayed by default GRADEPro GDT. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010156-sec-0040" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010156-sec-0040"></div> <section id="CD010156-sec-0041"> <h3 class="title">Description of studies</h3> <section id="CD010156-sec-0042"> <h4 class="title">Results of the search</h4> <p>The updated search retrieved 5088 references, 813 of which were duplicates. We excluded 3046 records after title and abstract screening, and 1229 after assessing the full‐text report (340 because of wrong study design, 334 because of wrong patient population, 451 because of wrong intervention, 3 because of wrong comparator, and 7 because the full report was not available, or data were not shown (classified as awaiting assessment or ongoing). Eighty‐five were duplicate reports of the same studies and nine reports (from two studies) were already included in our previous review (<a href="./references#CD010156-bbs2-0067" title="AndrésM , SiveraF , FalzonL , BuchbinderR , CarmonaL .Dietary supplements for chronic gout. Cochrane Database of Systematic Reviews2014, Issue 10. Art. No: CD010156. [DOI: 10.1002/14651858.CD010156.pub2]">Andres 2014</a>; <a href="#CD010156-fig-0001">Figure 1</a>). We did not identify any new eligible studies for this review update from the updated search. We also failed to identify any additional studies from ACR and EULAR abstracts or from a handsearch of the reference lists of included studies. </p> <div class="figure" id="CD010156-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD010156-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD010156-sec-0043"> <h4 class="title">Included studies</h4> <p>Two studies included in our previous review also met our inclusion criteria for this updated review (<a href="./references#CD010156-bbs2-0001" title="DalbethN , AmesR , GambleGD , HorneA , WongS , Kuhn-SherlockB , et al.Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomized controlled trial. Annals of the Rheumatic Diseases2012;71:929-34. Dalbeth N, Ames R, Gamble G, Horne A, Wong S, Kuhn-SherlockB , MacGibbonA .Daily intake of skim milk powder enriched with glycomacropeptide and G600 milk fat extract may reduce frequency of gout flares; results from a randomized, controlled trial. Arthritis and Rheumatism2011;63(SUPPL. 10):207. ">Dalbeth 2012</a>; <a href="./references#CD010156-bbs2-0002" title="Stamp LK, Frampton C, O'Donnell JL, Drake J, Chapman PT.Lack of effect of supplemental vitamin C on serum urate in patients with gout. Arthritis and Rheumatism2012;64(SUPPL. 10):S60-S61. StampLK , O'DonnellJL , FramptonC , DrakeJM , ZhangM , ChapmanPT .Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial. Arthritis and Rheumatism2013;65(6):1636-42. ">Stamp 2013</a>). Both studies were randomised controlled trials (RCT); and both were completed in New Zealand. See <a href="./references#CD010156-sec-0105" title="">Characteristics of included studies</a> for detailed information. </p> <p><a href="./references#CD010156-bbs2-0001" title="DalbethN , AmesR , GambleGD , HorneA , WongS , Kuhn-SherlockB , et al.Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomized controlled trial. Annals of the Rheumatic Diseases2012;71:929-34. Dalbeth N, Ames R, Gamble G, Horne A, Wong S, Kuhn-SherlockB , MacGibbonA .Daily intake of skim milk powder enriched with glycomacropeptide and G600 milk fat extract may reduce frequency of gout flares; results from a randomized, controlled trial. Arthritis and Rheumatism2011;63(SUPPL. 10):207. ">Dalbeth 2012</a> was a randomised double‐blind trial that tested enriched skim milk powder (SMP) for the prevention of gouty flares during a three‐month period. The study enrolled 120 participants with recurrent gout flares, from primary‐ and secondary‐care clinics, and from public advertisement. Participants were required to be at least 18 years old, fulfil the ACR criteria for gout and have had at least two gout flares in the preceding four months. People with lactose intolerance or severe renal failure (estimated glomerular filtration rate less than 30 mL/minute) were excluded. Enrolled participants were predominantly middle‐aged white men, with a long duration of gout (about 15 years). Gout was poorly controlled, as participants reported frequent gout flares, and one‐third of participants had tophaceous disease. Mean sUA was 0.42 mmol/L (slightly over normal). Mean serum creatinine was 91 µmol/L (normal). Half of the participants were taking allopurinol; this was not modified throughout the study. The proportion of participants receiving background non‐steroidal anti‐inflammatory drugs (NSAIDs) was 27%, colchicine 27% and prednisolone 13%. Participants were randomised to receive 1. lactose powder, 2. SMP or 3. SMP enriched with glycomacropeptides (GMP) 1.5 g and G600 milk fat extract 0.525 g. The primary end point was the change in frequency of gout flares, both defined as pain at rest greater than 3 on a 10‐point Likert scale and as participant self reported flare, registered by the participant in a daily flare diary, measured monthly for three months. Other outcomes measured were AEs rate, reduction in pain during the acute gout flares, participants global assessment, physical function evaluated through the Health Assessment Questionnaire (HAQ)‐II and the reduction of sUA. Other outcomes specified as being of interest in our review were not measured in this trial. Outcomes were reported at one, two and three months after exposure to the dairy interventions. </p> <p><a href="./references#CD010156-bbs2-0002" title="Stamp LK, Frampton C, O'Donnell JL, Drake J, Chapman PT.Lack of effect of supplemental vitamin C on serum urate in patients with gout. Arthritis and Rheumatism2012;64(SUPPL. 10):S60-S61. StampLK , O'DonnellJL , FramptonC , DrakeJM , ZhangM , ChapmanPT .Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial. Arthritis and Rheumatism2013;65(6):1636-42. ">Stamp 2013</a> was a randomised open trial assessing the effects of vitamin C compared with allopurinol in sUA reduction during an eight‐week period. Forty participants with gout fulfilling the ACR classification criteria with an sUA over 0.36 mmol/L at baseline were included. Enrolled participants were predominantly middle‐aged white men (mean 58 years of age, 90% men), who were overweight (mean body mass index: 31.2 kg/m<sup>2</sup>). Mean sUA at enrolment was 0.50 mmol/L, with normal renal function (estimated glomerular filtration rate over 66.7 mL/minute). Background use of diuretics was 27.5% and aspirin 30%. No data regarding disease duration or acute attacks rate were provided. Participants were stratified by allopurinol use at enrolment. Twenty participants were already on allopurinol (50%, mean dose at trial entry 345 mg daily) and were randomised to receive either an increase in allopurinol dose (10 participants) 50 to 100 mg daily or to receive vitamin C 500 mg/day (10 participants). Twenty participants were not taking allopurinol (50%) and were randomised to receive either allopurinol starting at 50 to 100 mg daily, with further dose adjustment at four weeks based on sUA level (10 participants) or vitamin C 500 mg daily (10 participants). Mean reduction of sUA at eight weeks was the primary end point of the trial. AE rate was also reported although it was not a pre‐specified end point. None of the other outcomes specified as being of interest in our review were measured in this trial. </p> <section id="CD010156-sec-0044"> <h5 class="title">Studies awaiting classification</h5> <p>We identified one trial that was published as an abstract in 2010, which is awaiting classification. It investigated artichoke verus placebo (<a href="./references#CD010156-bbs2-0007" title="ArychH , PishakO .Hepatoprotective properties of artichoke (cynara scolymus L) in patients with gout and hepatobiliary system pathology. European Journal of Medical Research2010;15(Suppl 1):218. ">Arych 2010</a>). See <a href="./references#CD010156-sec-0107" title="">Characteristics of studies awaiting classification</a> for details. </p> </section> <section id="CD010156-sec-0045"> <h5 class="title">Ongoing studies</h5> <p>We identified six ongoing trials assessing krill oil versus colchcine (<a href="./references#CD010156-bbs2-0008" title="ACTRN12618000770268.A randomized controlled trial of of krill oil on ultrasound detected inflammation in people with gout. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373777 (first received 5 October 2017). [Universal trial number (UTN) - U1111-1203-2300]">ACTRN12618000770268</a>); celery seed extract versus vitamin C versus starch (<a href="./references#CD010156-bbs2-0009" title="ChiCTR1900020614.The efficacy of celery seed extract in patients with primary gout: a randomized controlled trial. www.chictr.org.cn/showprojen.aspx?proj=34732 (first registered 10 January 2019). ">ChiCTR1900020614</a>); omega‐3 fatty acids versus placebo (<a href="./references#CD010156-bbs2-0010" title="ISRCTN79392964.Omega–3 fatty acids for the prophylaxis of acute attacks of gout on initiating urate-lowering treatment – a feasibility study for a randomised controlled trial (SOGAS). www.isrctn.com/ISRCTN79392964. [DOI: 10.1186/ISRCTN79392964]">ISRCTN79392964</a>); tart cherry juice (which contain anthocyanins) versus placebo (<a href="./references#CD010156-bbs2-0011" title="NCT03621215.The effect of tart cherry juice on risk of gout attacks. clinicaltrials.gov/ct2/show/NCT03621215 (first submitted 30 July 2018). ">NCT03621215</a>); 60 mL versus 120 mL oral dose of tart cherry extract (<a href="./references#CD010156-bbs2-0012" title="NCT03650140.Pharmacokinetics and pharmacodynamics of anthocyanins. clinicaltrials.gov/ct2/show/NCT03650140 (first submitted 13 August 2018). ">NCT03650140</a>); and probiotics versus placebo (<a href="./references#CD010156-bbs2-0013" title="NCT04199325.Probiotics for gout/hyperuricemia: randomized, double-blind, intervention, parallel controlled, multicenter. clinicaltrials.gov/ct2/show/NCT04199325 (first submitted 12 December 2019). ">NCT04199325</a>). See <a href="./references#CD010156-sec-0108" title="">Characteristics of ongoing studies</a> for details.  </p> </section> </section> <section id="CD010156-sec-0046"> <h4 class="title">Excluded studies</h4> <p><a href="./references#CD010156-bbs2-0005" title="YamanakaH , TaniguchiA , TsuboiH , KanoH , AsamiY .Hypouricaemic effects of yoghurt containing Lactobacillus gasseri PA-3 in patients with hyperuricaemia and/or gout: a randomised, double-blind, placebo-controlled study. Modern Rheumatology2019;29(1):146-50. ">Yamanaka 2019</a> was a randomised placebo‐controlled trial of eight weeks duration, completed in Japan, which assessed the effect of lactobacillus gasseri PA‐3 (provided in yoghurt at 8.5 x10^7 CFU/g) on sUA levels in 25 participants with hyperuricemia or gout. The study was deemed to be ineligible as study results for participants with gout were not presented separately. The corresponding author of the study was contacted in order to obtain raw data and results from participants with gout, but no answer was received. See <a href="./references#CD010156-sec-0106" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD010156-sec-0047"> <h3 class="title">Risk of bias in included studies</h3> <p>We assessed <a href="./references#CD010156-bbs2-0001" title="DalbethN , AmesR , GambleGD , HorneA , WongS , Kuhn-SherlockB , et al.Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomized controlled trial. Annals of the Rheumatic Diseases2012;71:929-34. Dalbeth N, Ames R, Gamble G, Horne A, Wong S, Kuhn-SherlockB , MacGibbonA .Daily intake of skim milk powder enriched with glycomacropeptide and G600 milk fat extract may reduce frequency of gout flares; results from a randomized, controlled trial. Arthritis and Rheumatism2011;63(SUPPL. 10):207. ">Dalbeth 2012</a> at unclear risk of bias, and <a href="./references#CD010156-bbs2-0002" title="Stamp LK, Frampton C, O'Donnell JL, Drake J, Chapman PT.Lack of effect of supplemental vitamin C on serum urate in patients with gout. Arthritis and Rheumatism2012;64(SUPPL. 10):S60-S61. StampLK , O'DonnellJL , FramptonC , DrakeJM , ZhangM , ChapmanPT .Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial. Arthritis and Rheumatism2013;65(6):1636-42. ">Stamp 2013</a> at unclear to high risk of bias (<a href="#CD010156-fig-0002">Figure 2</a>). See <a href="./references#CD010156-sec-0105" title="">Characteristics of included studies</a> for detailed information about the risks of bias. </p> <div class="figure" id="CD010156-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD010156-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> </div> <section id="CD010156-sec-0048"> <h4 class="title">Allocation</h4> <p>Both trials were at low risk of bias for random sequence generation. <a href="./references#CD010156-bbs2-0001" title="DalbethN , AmesR , GambleGD , HorneA , WongS , Kuhn-SherlockB , et al.Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomized controlled trial. Annals of the Rheumatic Diseases2012;71:929-34. Dalbeth N, Ames R, Gamble G, Horne A, Wong S, Kuhn-SherlockB , MacGibbonA .Daily intake of skim milk powder enriched with glycomacropeptide and G600 milk fat extract may reduce frequency of gout flares; results from a randomized, controlled trial. Arthritis and Rheumatism2011;63(SUPPL. 10):207. ">Dalbeth 2012</a> used a random block randomisation algorithm to generate the randomisation schedule. In <a href="./references#CD010156-bbs2-0002" title="Stamp LK, Frampton C, O'Donnell JL, Drake J, Chapman PT.Lack of effect of supplemental vitamin C on serum urate in patients with gout. Arthritis and Rheumatism2012;64(SUPPL. 10):S60-S61. StampLK , O'DonnellJL , FramptonC , DrakeJM , ZhangM , ChapmanPT .Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial. Arthritis and Rheumatism2013;65(6):1636-42. ">Stamp 2013</a>, the randomisation list was computer generated by an independent statistician. Randomisation was stratified by allopurinol use in permuted blocks of size four. </p> <p><a href="./references#CD010156-bbs2-0001" title="DalbethN , AmesR , GambleGD , HorneA , WongS , Kuhn-SherlockB , et al.Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomized controlled trial. Annals of the Rheumatic Diseases2012;71:929-34. Dalbeth N, Ames R, Gamble G, Horne A, Wong S, Kuhn-SherlockB , MacGibbonA .Daily intake of skim milk powder enriched with glycomacropeptide and G600 milk fat extract may reduce frequency of gout flares; results from a randomized, controlled trial. Arthritis and Rheumatism2011;63(SUPPL. 10):207. ">Dalbeth 2012</a> was at unclear risk of bias for allocation concealment; it stated that participants and study staff were blinded to treatment allocation, but no details of the actual method of allocation concealment was provided. <a href="./references#CD010156-bbs2-0002" title="Stamp LK, Frampton C, O'Donnell JL, Drake J, Chapman PT.Lack of effect of supplemental vitamin C on serum urate in patients with gout. Arthritis and Rheumatism2012;64(SUPPL. 10):S60-S61. StampLK , O'DonnellJL , FramptonC , DrakeJM , ZhangM , ChapmanPT .Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial. Arthritis and Rheumatism2013;65(6):1636-42. ">Stamp 2013</a> was at high risk of bias; there was no information provided about intervention concealment, and it was an open trial. </p> </section> <section id="CD010156-sec-0049"> <h4 class="title">Blinding</h4> <p><a href="./references#CD010156-bbs2-0001" title="DalbethN , AmesR , GambleGD , HorneA , WongS , Kuhn-SherlockB , et al.Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomized controlled trial. Annals of the Rheumatic Diseases2012;71:929-34. Dalbeth N, Ames R, Gamble G, Horne A, Wong S, Kuhn-SherlockB , MacGibbonA .Daily intake of skim milk powder enriched with glycomacropeptide and G600 milk fat extract may reduce frequency of gout flares; results from a randomized, controlled trial. Arthritis and Rheumatism2011;63(SUPPL. 10):207. ">Dalbeth 2012</a> was at low risk of performance and detection bias (self‐reported outcomes) and unclear risk of detection bias for assessor‐reported outcomes as it was unclear whether outcome assessors were blinded or not. In <a href="./references#CD010156-bbs2-0001" title="DalbethN , AmesR , GambleGD , HorneA , WongS , Kuhn-SherlockB , et al.Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomized controlled trial. Annals of the Rheumatic Diseases2012;71:929-34. Dalbeth N, Ames R, Gamble G, Horne A, Wong S, Kuhn-SherlockB , MacGibbonA .Daily intake of skim milk powder enriched with glycomacropeptide and G600 milk fat extract may reduce frequency of gout flares; results from a randomized, controlled trial. Arthritis and Rheumatism2011;63(SUPPL. 10):207. ">Dalbeth 2012</a>, all study agents were a cream‐coloured powder. This was administered daily as a 250 mL vanilla flavoured shake, so participants were unable to distinguish the type of milk they were taking. Study staff were also blinded to treatment allocation throughout the study. All study participants were treated in the same way, and examined according to the same protocol. </p> <p><a href="./references#CD010156-bbs2-0002" title="Stamp LK, Frampton C, O'Donnell JL, Drake J, Chapman PT.Lack of effect of supplemental vitamin C on serum urate in patients with gout. Arthritis and Rheumatism2012;64(SUPPL. 10):S60-S61. StampLK , O'DonnellJL , FramptonC , DrakeJM , ZhangM , ChapmanPT .Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial. Arthritis and Rheumatism2013;65(6):1636-42. ">Stamp 2013</a> was an open‐label study, so both participants and physicians were aware of treatment allocation. Hence there was high risk of performance bias and detection bias for self‐reported outcomes, but its influence on the measurement of laboratory outcomes (sUA levels) was probably unimportant, therefore we judged detection bias due to assessor‐reported outcomes at unclear risk. </p> </section> <section id="CD010156-sec-0050"> <h4 class="title">Incomplete outcome data</h4> <p>Both trials were judged to be at low risk of attrition bias. In <a href="./references#CD010156-bbs2-0001" title="DalbethN , AmesR , GambleGD , HorneA , WongS , Kuhn-SherlockB , et al.Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomized controlled trial. Annals of the Rheumatic Diseases2012;71:929-34. Dalbeth N, Ames R, Gamble G, Horne A, Wong S, Kuhn-SherlockB , MacGibbonA .Daily intake of skim milk powder enriched with glycomacropeptide and G600 milk fat extract may reduce frequency of gout flares; results from a randomized, controlled trial. Arthritis and Rheumatism2011;63(SUPPL. 10):207. ">Dalbeth 2012</a>, of the 120 participants who started, 102 (85%) completed the three‐month study (two discontinued for AEs, eight were lost to follow‐up, and eight continued the study without taking the study medication after an AE). No significant differences were noted between groups in the dropout rate. </p> <p>All 40 randomised participants completed the eight‐week study period in <a href="./references#CD010156-bbs2-0002" title="Stamp LK, Frampton C, O'Donnell JL, Drake J, Chapman PT.Lack of effect of supplemental vitamin C on serum urate in patients with gout. Arthritis and Rheumatism2012;64(SUPPL. 10):S60-S61. StampLK , O'DonnellJL , FramptonC , DrakeJM , ZhangM , ChapmanPT .Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial. Arthritis and Rheumatism2013;65(6):1636-42. ">Stamp 2013</a>. </p> </section> <section id="CD010156-sec-0051"> <h4 class="title">Selective reporting</h4> <p>In <a href="./references#CD010156-bbs2-0001" title="DalbethN , AmesR , GambleGD , HorneA , WongS , Kuhn-SherlockB , et al.Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomized controlled trial. Annals of the Rheumatic Diseases2012;71:929-34. Dalbeth N, Ames R, Gamble G, Horne A, Wong S, Kuhn-SherlockB , MacGibbonA .Daily intake of skim milk powder enriched with glycomacropeptide and G600 milk fat extract may reduce frequency of gout flares; results from a randomized, controlled trial. Arthritis and Rheumatism2011;63(SUPPL. 10):207. ">Dalbeth 2012</a>, all outcomes planned in the protocol that was registered at the Australian &amp; New Zealand Clinical Trial Registry were reported in the paper. <a href="./references#CD010156-bbs2-0001" title="DalbethN , AmesR , GambleGD , HorneA , WongS , Kuhn-SherlockB , et al.Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomized controlled trial. Annals of the Rheumatic Diseases2012;71:929-34. Dalbeth N, Ames R, Gamble G, Horne A, Wong S, Kuhn-SherlockB , MacGibbonA .Daily intake of skim milk powder enriched with glycomacropeptide and G600 milk fat extract may reduce frequency of gout flares; results from a randomized, controlled trial. Arthritis and Rheumatism2011;63(SUPPL. 10):207. ">Dalbeth 2012</a> also reported the findings of a post hoc comparison between two interventions (GMP/G600 SMP and lactose control) and their effects on the study's primary end point (change in gout flare frequency), although not the results of the third intervention (standard SMP). The same selective reporting occurred in the study authors' discussion of GMP/G600 SMP effect on lowering diastolic blood pressure; they only reported the results of the post hoc comparison with the lactose control group. Hence, this study was judged to be at unclear risk of selective reporting bias. </p> <p>In <a href="./references#CD010156-bbs2-0002" title="Stamp LK, Frampton C, O'Donnell JL, Drake J, Chapman PT.Lack of effect of supplemental vitamin C on serum urate in patients with gout. Arthritis and Rheumatism2012;64(SUPPL. 10):S60-S61. StampLK , O'DonnellJL , FramptonC , DrakeJM , ZhangM , ChapmanPT .Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial. Arthritis and Rheumatism2013;65(6):1636-42. ">Stamp 2013</a>, all pre‐defined outcomes in the protocol that was registered at the Australian &amp; New Zealand Clinical Trial Registry were reported in the results, and there was low risk of reporting bias. </p> </section> <section id="CD010156-sec-0052"> <h4 class="title">Other potential sources of bias</h4> <p>In <a href="./references#CD010156-bbs2-0001" title="DalbethN , AmesR , GambleGD , HorneA , WongS , Kuhn-SherlockB , et al.Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomized controlled trial. Annals of the Rheumatic Diseases2012;71:929-34. Dalbeth N, Ames R, Gamble G, Horne A, Wong S, Kuhn-SherlockB , MacGibbonA .Daily intake of skim milk powder enriched with glycomacropeptide and G600 milk fat extract may reduce frequency of gout flares; results from a randomized, controlled trial. Arthritis and Rheumatism2011;63(SUPPL. 10):207. ">Dalbeth 2012</a>, groups were well matched at baseline, except for higher diuretic use in the GMP/G600 SMP group. The commencement or discontinuation rates of diuretics, allopurinol, colchicine, prednisone, or non‐steroid anti‐inflammatory drugs (NSAIDs) did not differ between groups throughout the follow‐up period. Compliance was acceptable in all groups (rate of participants who dropped the study or discontinued the dairy product ranged between 13% and 18%). It is noteworthy that study funding was provided by LactoPharma (a joint venture between Fonterra Ltd, Fonterra R&amp;D Ltd and Auckland UniServices Ltd) and the New Zealand Government Foundation for Research Science and Technology. The role of the company in the study was not clearly addressed. The review authors BK‐S, AM, and KP are employees of Fonterra Co‐operative Group Ltd. The review authors AM, ND, and KP are named inventors on a patent application related to milk products and gout. We judged this study to be at an unclear risk of other bias. </p> <p>Participant adherence to medications was not clearly described in <a href="./references#CD010156-bbs2-0002" title="Stamp LK, Frampton C, O'Donnell JL, Drake J, Chapman PT.Lack of effect of supplemental vitamin C on serum urate in patients with gout. Arthritis and Rheumatism2012;64(SUPPL. 10):S60-S61. StampLK , O'DonnellJL , FramptonC , DrakeJM , ZhangM , ChapmanPT .Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial. Arthritis and Rheumatism2013;65(6):1636-42. ">Stamp 2013</a>, but oxypurinol and ascorbic acid levels were measured in all study participants, which could be considered an indirect measure of adherence. This study was at low risk of other bias. </p> </section> </section> <section id="CD010156-sec-0053"> <h3 class="title" id="CD010156-sec-0053">Effects of interventions</h3> <p>See: <a href="./full#CD010156-tbl-0001"><b>Summary of findings 1</b> Skim milk enriched with GMP/G600 compared with skim milk, plus lactose powder for chronic gout</a>; <a href="./full#CD010156-tbl-0002"><b>Summary of findings 2</b> Vitamin C compared with allopurinol for chronic gout</a> </p> <p>We did not pool data from the two included studies, since they each evaluated different supplements. Therefore, we have two comparisons, with one trial in each one. See <a href="./full#CD010156-tbl-0001">summary of findings Table 1</a> and <a href="./full#CD010156-tbl-0002">summary of findings Table 2</a> for more details. </p> <section id="CD010156-sec-0054"> <h4 class="title">Skim milk enriched with GMP/G600 versus standard skim milk or lactose powder</h4> <section id="CD010156-sec-0055"> <h5 class="title">Major outcomes</h5> <section id="CD010156-sec-0056"> <h6 class="title">Acute gout flares</h6> <p><a href="./references#CD010156-bbs2-0001" title="DalbethN , AmesR , GambleGD , HorneA , WongS , Kuhn-SherlockB , et al.Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomized controlled trial. Annals of the Rheumatic Diseases2012;71:929-34. Dalbeth N, Ames R, Gamble G, Horne A, Wong S, Kuhn-SherlockB , MacGibbonA .Daily intake of skim milk powder enriched with glycomacropeptide and G600 milk fat extract may reduce frequency of gout flares; results from a randomized, controlled trial. Arthritis and Rheumatism2011;63(SUPPL. 10):207. ">Dalbeth 2012</a> found a significant reduction in the rate of gout flares with all three dairy products (skim milk enriched with GMP/G600, standard skim milk (SMP), and lactose powder) over the three‐month study period; however, there were no differences in the number of gout flares between groups. </p> <p>After combining the two control groups (standard SMP and lactose powder) <b>–</b> using the raw data provided by the study authors <b>–</b> and calculating the standard deviation (SD) from the 95% confidence interval (CI), we found that the rate of gout flares in the GMP/G600 SMP group was 0.49 ± 1.52 flares per month compared with 0.70 ± 1.28 flares per month in the combined control group. </p> <p>After three months of treatment, the change in the number of gout flares per month between the GMP/G600 SMP and the control groups was inconclusive (mean difference (MD) ‐0.21, 95% CI ‐0.76 to 0.34; 1 study, 120 participants; low‐quality evidence; <a href="./references#CD010156-fig-0004" title="">Analysis 1.1</a>); the absolute difference was 21% lower in the GMP/G600 SMP group (76% lower to 34% higher). We downgraded the evidence for bias and imprecision. The difference between groups was inconclusive, and from the review team's perspective, was not clinically relevant. </p> </section> <section id="CD010156-sec-0057"> <h6 class="title">Study withdrawals due to adverse events (AE)</h6> <p>Withdrawals due to adverse events were similar between the three study groups, 7/40 participants dropped out because of an AE in the GMP/G600 SMP group and 11/80 participants dropped out from the joint control groups (risk ratio (RR) 1.27, 95% CI 0.53 to 3.03; 1 study, 120 participants; low‐quality evidence; <a href="./references#CD010156-fig-0005" title="">Analysis 1.2</a>). The absolute difference was 4% more withdrawals from the GMP/G600 SMP group (10% fewer to 18% more). We downgraded the evidence for bias and imprecision. </p> </section> <section id="CD010156-sec-0058"> <h6 class="title">Serum uric acid (sUA) reduction</h6> <p>sUA reduction was similar between groups (‐0.024 ± 0.066 in GMP/G600 SMP versus ‐0.010 ± 0.068 in control group; MD ‐0.01, 95% CI ‐0.04 to 0.01; 1 study, 102 participants analysed; low‐quality evidence; <a href="./references#CD010156-fig-0006" title="">Analysis 1.3</a>). The absolute change was 0.01 mmol/L more reduction in the GMP/G600 SMP group (0.04 lower to 0.01 higher). We downgraded the evidence for bias and imprecision. Data regarding sUA normalisation were not provided. </p> </section> <section id="CD010156-sec-0059"> <h6 class="title">Joint pain reduction</h6> <p>GMP/G600 SMP reduced pain (measured on a 10‐point Likert scale) during self‐reported gout flares more than the control treatments (‐1.97 ± 2.28 in GMP/G600 SMP group versus ‐0.94 ± 2.25 in controls, using a 0‐ to 10‐point Likert scale; MD ‐1.03, 95% CI ‐1.89 to ‐0.17; 1 study, 120 participants; low‐quality evidence; <a href="./references#CD010156-fig-0007" title="">Analysis 1.4</a>). The absolute difference was 10% less pain during gout flares in the GMP/G600 SMP group (1% lower to 20% lower). We downgraded the evidence for bias and imprecision. This finding might have a limited interest from a clinical perspective. </p> </section> <section id="CD010156-sec-0060"> <h6 class="title">Participant global assessment</h6> <p>The study authors reported that scores improved similarly between groups throughout the trial, but data were not given. We were unable to obtain the raw data from the study authors. </p> </section> <section id="CD010156-sec-0061"> <h6 class="title">Total AEs</h6> <p>The rate of adverse events were similar between the three study groups (19/40 in the GMP/G600 SMP group versus 28/80 in the control groups; RR 0.97, 95% CI 0.66 to 1.45; 1 study, 120 participants; low‐quality evidence; <a href="./references#CD010156-fig-0008" title="">Analysis 1.5</a>); absolute risk difference: 1% less adverse events (1% fewer to 2% more). Gastrointestinal events such as nausea and diarrhoea were the most commonly reported adverse effects. </p> </section> <section id="CD010156-sec-0062"> <h6 class="title">Tophus regression</h6> <p>The study did not measure this outcome.</p> </section> </section> <section id="CD010156-sec-0063"> <h5 class="title">Minor outcomes</h5> <section id="CD010156-sec-0064"> <h6 class="title">Physical function (or disability)</h6> <p>In physical function, assessed using HAQ‐II, no differences were found between groups at three months (0.08 ± 0.23 in the GMP/G600 SMP group versus 0.11 ± 0.32 in the control groups; MD ‐0.03, 95% CI ‐0.14 to 0.08) (<a href="./references#CD010156-fig-0009" title="">Analysis 1.6</a>). </p> </section> <section id="CD010156-sec-0065"> <h6 class="title">Serious AEs</h6> <p>The risk of serious adverse events (2/40 in the GMP/G600 SMP group versus 3/80 in the control groups) was also similar between groups (RR 1.33, 95% CI 0.23 to 7.66). We downgraded the evidence for bias and imprecision (<a href="./references#CD010156-fig-0010" title="">Analysis 1.7</a>). </p> </section> </section> </section> <section id="CD010156-sec-0066"> <h4 class="title">Vitamin C versus allopurinol</h4> <section id="CD010156-sec-0067"> <h5 class="title">Major outcomes</h5> <section id="CD010156-sec-0068"> <h6 class="title">Acute gout flares</h6> <p>The study did not measure this outcome.</p> </section> <section id="CD010156-sec-0069"> <h6 class="title">Study withdrawals due to adverse events (AE)</h6> <p>The study did not measure this outcome.</p> </section> <section id="CD010156-sec-0070"> <h6 class="title">Serum uric acid (sUA) reduction</h6> <p><a href="./references#CD010156-bbs2-0002" title="Stamp LK, Frampton C, O'Donnell JL, Drake J, Chapman PT.Lack of effect of supplemental vitamin C on serum urate in patients with gout. Arthritis and Rheumatism2012;64(SUPPL. 10):S60-S61. StampLK , O'DonnellJL , FramptonC , DrakeJM , ZhangM , ChapmanPT .Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial. Arthritis and Rheumatism2013;65(6):1636-42. ">Stamp 2013</a> found that at the end of the eight‐week study period, the level of sUA was reduced more in the allopurinol group than in the vitamin C group (MD 0.10, 95% CI 0.06 to 0.15; 1 study, 40 participants; low‐quality evidence; <a href="./references#CD010156-fig-0011" title="">Analysis 2.1</a>). The absolute risk difference was 0.10 mmol/L more reduction in the allopurinol group (0.06 mmol/L higher to 0.15 mmol/L higher). We considered the higher reduction of sUA observed with allopurinol over vitamin C to be clinically relevant. We downgraded the evidence twice for serious bias. </p> <p>The study authors conducted a subgroup analysis, based on whether participants were taking allopurinol at study entry; they reported that overall, it did not affect treatment response, but there were different responses between those who were already taking it, and those who started once in the study. Those in the allopurinol group who had not been taking it when they entered the study had a greater reduction in sUA than those in the vitamin C group (MD 0.15, 95% CI 0.08 to 0.22; 20 participants). Those in the allopurinol group who were on it when they entered the study had similar reductions in sUA than those taking vitamin C (MD 0.06, 95% CI ‐0.01 to 0.13; 20 participants; <a href="./references#CD010156-fig-0012" title="">Analysis 2.2</a>; <a href="#CD010156-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD010156-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: Vitamin C versus allopurinol, outcome: sUA reduction; subgroup analysis [mmol/L]" data-id="CD010156-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: Vitamin C versus allopurinol, outcome: sUA reduction; subgroup analysis [mmol/L] </p> </div> </div> </div> </section> <section id="CD010156-sec-0071"> <h6 class="title">Joint pain reduction</h6> <p>The study did not measure this outcome.</p> </section> <section id="CD010156-sec-0072"> <h6 class="title">Participant global assessment</h6> <p>The study did not measure this outcome.</p> </section> <section id="CD010156-sec-0073"> <h6 class="title">Total AEs</h6> <p>No AEs were detected in either group.</p> </section> <section id="CD010156-sec-0074"> <h6 class="title">Tophus regression</h6> <p>The study did not measure this outcome.</p> </section> </section> <section id="CD010156-sec-0075"> <h5 class="title">Minor outcomes</h5> <section id="CD010156-sec-0076"> <h6 class="title">Physical function (or disability)</h6> <p>The study did not measure this outcome.</p> </section> <section id="CD010156-sec-0077"> <h6 class="title">Serious AEs</h6> <p>The study did not measure this outcome.</p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010156-sec-0078" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010156-sec-0078"></div> <section id="CD010156-sec-0079"> <h3 class="title" id="CD010156-sec-0079">Summary of main results</h3> <p>We only identified two published randomised controlled trials (RCTs) that tested the benefits of two different dietary supplements in people with chronic gout. One trial assessed enriched skim milk (120 participants); the other evaluated vitamin C against allopurinol (40 participants). </p> <section id="CD010156-sec-0080"> <h4 class="title">Skim milk enriched with GMP/G600</h4> <p>One trial, including 120 participants and judged to be of low‐quality due to bias and imprecision, compared skim milk (SMP) enriched with GMP/G600 against standard SMP or lactose powder. There results were similar between groups for frequency of gout flares, rate of adverse events (AE; gastrointestinal disturbances were the most commonly reported) and serum uric acid (sUA) reduction. Participants in the GMP/G600 SMP group reported a greater reduction in pain from self‐reported gout flares, but the amount of reduction might be of doubtful clinical relevance. Withdrawal due to AEs did not differ between groups. The study did not assess tophus regression or health‐related quality of life. </p> <p>Compared with standard skim milk or lactose powder, skim milk enriched with GMP and G600 was of unclear benefit in reducing flares of gout based on a single trial impacted by risk of bias and imprecision. </p> </section> <section id="CD010156-sec-0081"> <h4 class="title">Vitamin C</h4> <p>One trial, with 40 participants, and judged to be of low‐quality being downgraded twice for bias, evaluated the effect of vitamin C on sUA levels compared with allopurinol, over eight weeks. Participants were stratified according to their use of allopurinol at the entry of the study. Overall, the reduction of sUA with vitamin C was less than with allopurinol. There were no AEs reported in either group. This study did not measure any other outcomes of interest for this review. </p> <p>Compared with allopurinol (the standard agent used in clinical practice for people with gout), vitamin C showed no benefit in reducing sUA levels in people with gout, a conclusion based on a single trial that was impacted by selection. performance and deteciton bias. </p> </section> </section> <section id="CD010156-sec-0082"> <h3 class="title" id="CD010156-sec-0082">Overall completeness and applicability of evidence</h3> <p>Enriched SMP and vitamin C were the only dietary supplements tested in gout, based on our search. </p> <p>Participants in <a href="./references#CD010156-bbs2-0001" title="DalbethN , AmesR , GambleGD , HorneA , WongS , Kuhn-SherlockB , et al.Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomized controlled trial. Annals of the Rheumatic Diseases2012;71:929-34. Dalbeth N, Ames R, Gamble G, Horne A, Wong S, Kuhn-SherlockB , MacGibbonA .Daily intake of skim milk powder enriched with glycomacropeptide and G600 milk fat extract may reduce frequency of gout flares; results from a randomized, controlled trial. Arthritis and Rheumatism2011;63(SUPPL. 10):207. ">Dalbeth 2012</a> did not seem very representative of the average gout population, as they reported very recurrent flares (3.9 to 5.1 flares in the four months preceding the enrolment), and 20% to 43% showed tophi. This might be attributable to ethnic issues, as the study took place in New Zealand, and Maori and Pacific people have been shown to have a severe form of gout (<a href="./references#CD010156-bbs2-0049" title="RoseBS .Gout in Maoris. Seminars of Arthritis and Rheumatism1975;5(2):121-45.">Rose 1975</a>); however, over 70% of the participants in <a href="./references#CD010156-bbs2-0001" title="DalbethN , AmesR , GambleGD , HorneA , WongS , Kuhn-SherlockB , et al.Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomized controlled trial. Annals of the Rheumatic Diseases2012;71:929-34. Dalbeth N, Ames R, Gamble G, Horne A, Wong S, Kuhn-SherlockB , MacGibbonA .Daily intake of skim milk powder enriched with glycomacropeptide and G600 milk fat extract may reduce frequency of gout flares; results from a randomized, controlled trial. Arthritis and Rheumatism2011;63(SUPPL. 10):207. ">Dalbeth 2012</a> were white. So, the recruited participants would be representative of a severe gout population, more often seen in a hospital gout clinic. Other characteristics, such as being middle aged (mean range 56 to 57 years), and predominantly male (88% to 93%), are typical of the disease. The low use of allopurinol (53% to 55%) or colchicine (18% to 33%) is comparable to other studies, in which many participants in the clinical setting are either never prescribed, or do not adhere to urate‐lowering therapy, or flare prophylaxis is seldom considered (<a href="./references#CD010156-bbs2-0044" title="Perez-RuizF , CarmonaL , García de YébenesMJ , PascualE , De MiguelE , UreñaI , et al.An audit of the variability of diagnosis and management of gout in the rheumatology setting: the Gout Evaluation and Management study. Journal of Clinical Rheumatology2011;17:349-55.">Perez‐Ruiz 2011</a>). Participants recruited in <a href="./references#CD010156-bbs2-0002" title="Stamp LK, Frampton C, O'Donnell JL, Drake J, Chapman PT.Lack of effect of supplemental vitamin C on serum urate in patients with gout. Arthritis and Rheumatism2012;64(SUPPL. 10):S60-S61. StampLK , O'DonnellJL , FramptonC , DrakeJM , ZhangM , ChapmanPT .Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial. Arthritis and Rheumatism2013;65(6):1636-42. ">Stamp 2013</a> appeared representative of people with gout seen commonly in clinical practice (<a href="./references#CD010156-bbs2-0065" title="Yu T-F.Diversity of gouty features in gouty arthritis. Seminars in Arthritis and Rheumatism1984;13:360-8.">Yu 1984</a>). </p> <p>The dietary supplements identified in this review comprised two different targets of the management of chronic gout (<a href="./references#CD010156-bbs2-0048" title="RichetteP , DohertyM , PascualE , BarskovaV , BecceF , Castañeda-SanabriaJ , et al.2016 updated EULAR evidence-based recommendations for the management of gout. Annals of the Rheumatic Diseases2017;76(1):29-42. [DOI: 10.1136/annrheumdis-2016-209707]">Richette 2017</a>). Enriched milk powder was tested as an anti‐inflammatory agent to reduce the occurrence of acute gout flares, while vitamin C acted as an sUA‐lowering agent to pursue crystal dissolution. However, the effect of these supplements appears negligible, and a similar conclusion was reported by a recent systematic literature review (<a href="./references#CD010156-bbs2-0064" title="YangJ , LiG , XiongD , ChonTY , BauerBA .The impact of natural product dietary supplements on patients with gout: a systematic review and meta-analysis of randomized controlled trials. Evidence-based Complementary and Alternative Medicine: ECAM2020;2020:7976130.">Yang 2020</a>). Moreover, considering the need to achieve a persistent reduction in sUA levels to achieve monosodium urate (MSU) crystal dissolution, the effect noted with vitamin C seems trivial in terms of reaching this target (<a href="./references#CD010156-bbs2-0048" title="RichetteP , DohertyM , PascualE , BarskovaV , BecceF , Castañeda-SanabriaJ , et al.2016 updated EULAR evidence-based recommendations for the management of gout. Annals of the Rheumatic Diseases2017;76(1):29-42. [DOI: 10.1136/annrheumdis-2016-209707]">Richette 2017</a>). Perhaps, the dose of vitamin C tested in <a href="./references#CD010156-bbs2-0002" title="Stamp LK, Frampton C, O'Donnell JL, Drake J, Chapman PT.Lack of effect of supplemental vitamin C on serum urate in patients with gout. Arthritis and Rheumatism2012;64(SUPPL. 10):S60-S61. StampLK , O'DonnellJL , FramptonC , DrakeJM , ZhangM , ChapmanPT .Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial. Arthritis and Rheumatism2013;65(6):1636-42. ">Stamp 2013</a> was insufficient, as previous reports noted a significant sUA reduction (through increasing uric acid urinary excretion) with larger doses, in hyperuricaemic participants without gout (<a href="./references#CD010156-bbs2-0014" title="BergerL , GersonCD , YüTF .The effect of ascorbic acid on uric acid excretion with a commentary on the renal handling of ascorbic acid. American Journal of Medicine1977;62(1):71-6.">Berger 1977</a>; <a href="./references#CD010156-bbs2-0033" title="MitchWE , JohnsonMW , KirshenbaumJM , LopezRE .Effect of large oral doses of ascorbic acid on uric acid excretion by normal subjects. Clinical Pharmacology and Therapeutics1981;29(3):318-21.">Mitch 1981</a>; <a href="./references#CD010156-bbs2-0058" title="SteinHB , HasanA , FoxIH .Ascorbic acid-induced uricosuria. A consequency of megavitamin therapy. Annals of Internal Medicine1976;84:385-8.">Stein 1976</a>). Other supplements have been tested in people with asymptomatic hyperuricaemia, but not in gout. Reducing sUA levels to control hyperuricaemia will lead to MSU crystals being dissolved from joints or tissues, but other aims should be considered in people with gout, such as a reduction in the number of acute attacks, an improvement in health‐related quality of life, or regression of the tophi. An anti‐inflammatory effect to control acute episodes or the persistent subclinical inflammation would also be suitable aims for people with gout. Based on this, we deem that the studies in people with hyperuricaemia are not entirely applicable to people with gout, and thus, we did not include them in this review. </p> <p>Other supplements, such as amino acids, polyunsaturated fatty acids (PUFA), or antioxidants, are widely used for the treatment of several disorders, but our search did not identify any studies of these interventions. In addition, some dietary interventions, such as black tea or cherries, have shown some effect in reducing sUA levels or controlling acute attacks in people with hyperuricaemia or gout. However, these types of interventions could not really be considered supplements, unless specific components, considered to have potential benefits, were to be extracted and purified so they could be individually tested, similar to the evaluation of the glycomacropeptides in <a href="./references#CD010156-bbs2-0001" title="DalbethN , AmesR , GambleGD , HorneA , WongS , Kuhn-SherlockB , et al.Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomized controlled trial. Annals of the Rheumatic Diseases2012;71:929-34. Dalbeth N, Ames R, Gamble G, Horne A, Wong S, Kuhn-SherlockB , MacGibbonA .Daily intake of skim milk powder enriched with glycomacropeptide and G600 milk fat extract may reduce frequency of gout flares; results from a randomized, controlled trial. Arthritis and Rheumatism2011;63(SUPPL. 10):207. ">Dalbeth 2012</a>. Therefore, they were outside the scope for this review. </p> <p>Lifestyle interventions were addressed by another Cochrane Review (<a href="./references#CD010156-bbs2-0035" title="MoiJHY , SriranganathanMK , EdwardsCJ , BuchbinderR .Lifestyle interventions for chronic gout. Cochrane Database of Systematic Reviews2013, Issue 5. Art. No: CD010039. [DOI: 10.1002/14651858.CD010039.pub2]">Moi 2013</a>). </p> <p>Population‐based studies have identified a number of diet patterns that may be associated with an increased risk of developing hyperuricaemia and gout, such as the intake of alcohol or high fructose‐enriched beverages. However, giving diet advice based on these results, with no confirmation through intervention studies, warrants caution (<a href="./references#CD010156-bbs2-0050" title="RoseG .Sick individuals and sick populations. International Journal of Epidemiology1985;14:32-8.">Rose 1985</a>). The effect of these interventions in the individual participant is likely to be small or lacking, especially in people with gout, where this effect appears to us to be incapable of reducing sUA to the level that is required to make all MSU crystal dissolve. In addition, the effect could vary as the targeted populations are different; risk factors for developing hyperuricemia, and eventually gout, are reported in at‐risk populations (thus, they are still healthy), while the use of dietary supplements proposed and tested here are aimed at people who are already suffering from chronic gout. </p> </section> <section id="CD010156-sec-0083"> <h3 class="title" id="CD010156-sec-0083">Quality of the evidence</h3> <p>Our search identified only two studies, enrolling 160 participants. It is likely that the small number of trials identified reflects the lack of high‐quality research in this area, rather than publication bias. We judged the included studies to be of low quality; issues regarding the study design and imprecision of results reduced the quality of the results, with particular concerns in selection bias and absence of blinding. Relevant outcomes for gout management, such as prevention of acute attacks or sUA reduction, were only assessed in a single study each, and tophus regression was not reported in the included studies. </p> </section> <section id="CD010156-sec-0084"> <h3 class="title" id="CD010156-sec-0084">Potential biases in the review process</h3> <p>Despite a broad search retrieving more than 2800 hits, we only identified two trials that fulfilled the inclusion criteria for this review. We included several different terms for gout and for dietary supplementation (as a general intervention and for different individual ones). It could be possible that some relevant RCTs were missed, due to the lag between the search date (August 2020) and review publication, but this possibility seems very low. </p> </section> <section id="CD010156-sec-0085"> <h3 class="title" id="CD010156-sec-0085">Agreements and disagreements with other studies or reviews</h3> <p>The initial version of this review was the first systematic literature review assessing the efficacy and safety of dietary supplementation in people with gout (<a href="./references#CD010156-bbs2-0067" title="AndrésM , SiveraF , FalzonL , BuchbinderR , CarmonaL .Dietary supplements for chronic gout. Cochrane Database of Systematic Reviews2014, Issue 10. Art. No: CD010156. [DOI: 10.1002/14651858.CD010156.pub2]">Andres 2014</a>). The current update did not identify any newly published evidence in recent years on the topic. However, we retrieved a number of ongoing trials for which there are still no available results (see <a href="./references#CD010156-sec-0107" title="">Characteristics of studies awaiting classification</a> and <a href="./references#CD010156-sec-0108" title="">Characteristics of ongoing studies</a>). Considering their registered protocols, they are potential candidates for a further update of this review. The dietary supplements that are being studied are krill oil compared to colchicine to reduce inflammation and pain in chronic gout; celery seed extract compared to vitamin C or starch to reducing sUA levels; omega‐3 fatty acids compared with placebo, designed as a feasible trial; tart cherry juice concentrate compared against a fruit‐flavoured placebo drink to reduce the occurrence of gout flares; and probiotics compared to placebo to assess sUA levels reduction. </p> <p>One trial identified in our search evaluated the pharmacokinetics and pharmacodynamics of anthocyanins in chronic gout, but recently suspended recruitment due to the COVID‐19 pandemic, with no resuming date yet; another, using artichoke supplements, communicated their results in a 2010 conference, but remains unpublished. </p> <p>In summary, there are a number of dietary supplements currently being assessed for different outcomes of chronic gout. When the findings of the ongoing trials are published, they should be critically reviewed in a subsequent update of this review, with a chance of modifying the current conclusions. </p> <p>Several studies, including one meta‐analysis of RCTs (<a href="./references#CD010156-bbs2-0026" title="JuraschekSP , Miller ER 3rd, GelberAC .Effect of oral vitamin C supplementation on serum uric acid: a meta-analysis of randomized controlled trials. Arthritis Care &amp; Research2011;63(9):1295-306.">Juraschek 2011</a>), have reported that vitamin C supplementation may lower sUA levels. However, these studies have generally been of low quality, and have largely been performed in either healthy people or people with asymptomatic hyperuricaemia. In addition, the median sUA levels in the included populations were close to the upper limit of normality (<a href="./references#CD010156-bbs2-0025" title="HuangHY , AppelLJ , ChoiMJ , GelberAC , CharlestonJ , NorkusEP , et al.The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial. Arthritis and Rheumatism2005;52(6):1843-7.">Huang 2005</a>). Therefore, we consider it doubtful that these results could be extrapolated to people with gout. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010156-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/urn:x-wiley:14651858:media:CD010156:CD010156-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD010156-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_t/tCD010156-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/full#CD010156-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010156-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/urn:x-wiley:14651858:media:CD010156:CD010156-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD010156-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_t/tCD010156-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/full#CD010156-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010156-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/urn:x-wiley:14651858:media:CD010156:CD010156-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: Vitamin C versus allopurinol, outcome: sUA reduction; subgroup analysis [mmol/L]" data-id="CD010156-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_t/tCD010156-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: Vitamin C versus allopurinol, outcome: sUA reduction; subgroup analysis [mmol/L] </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/full#CD010156-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010156-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/urn:x-wiley:14651858:media:CD010156:CD010156-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Skim milk powder (SMP; GMP/G600) versus control (SMP/lactose), Outcome 1: Acute gout flares (per month, after 3 months of treatment)" data-id="CD010156-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_t/tCD010156-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Skim milk powder (SMP; GMP/G600) versus control (SMP/lactose), Outcome 1: Acute gout flares (per month, after 3 months of treatment) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/references#CD010156-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010156-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/urn:x-wiley:14651858:media:CD010156:CD010156-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Skim milk powder (SMP; GMP/G600) versus control (SMP/lactose), Outcome 2: Study withdrawals due to adverse events" data-id="CD010156-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_t/tCD010156-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Skim milk powder (SMP; GMP/G600) versus control (SMP/lactose), Outcome 2: Study withdrawals due to adverse events </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/references#CD010156-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010156-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/urn:x-wiley:14651858:media:CD010156:CD010156-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Skim milk powder (SMP; GMP/G600) versus control (SMP/lactose), Outcome 3: Serum uric acid reduction" data-id="CD010156-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_t/tCD010156-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Skim milk powder (SMP; GMP/G600) versus control (SMP/lactose), Outcome 3: Serum uric acid reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/references#CD010156-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010156-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/urn:x-wiley:14651858:media:CD010156:CD010156-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Skim milk powder (SMP; GMP/G600) versus control (SMP/lactose), Outcome 4: Joint pain reduction (during gout flares)" data-id="CD010156-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_t/tCD010156-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Skim milk powder (SMP; GMP/G600) versus control (SMP/lactose), Outcome 4: Joint pain reduction (during gout flares) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/references#CD010156-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010156-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/urn:x-wiley:14651858:media:CD010156:CD010156-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Skim milk powder (SMP; GMP/G600) versus control (SMP/lactose), Outcome 5: Total number of adverse events" data-id="CD010156-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_t/tCD010156-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Skim milk powder (SMP; GMP/G600) versus control (SMP/lactose), Outcome 5: Total number of adverse events </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/references#CD010156-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010156-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/urn:x-wiley:14651858:media:CD010156:CD010156-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Skim milk powder (SMP; GMP/G600) versus control (SMP/lactose), Outcome 6: Physical function" data-id="CD010156-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_t/tCD010156-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Skim milk powder (SMP; GMP/G600) versus control (SMP/lactose), Outcome 6: Physical function </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/references#CD010156-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010156-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/urn:x-wiley:14651858:media:CD010156:CD010156-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Skim milk powder (SMP; GMP/G600) versus control (SMP/lactose), Outcome 7: Serious adverse events" data-id="CD010156-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_t/tCD010156-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Skim milk powder (SMP; GMP/G600) versus control (SMP/lactose), Outcome 7: Serious adverse events </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/references#CD010156-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010156-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/urn:x-wiley:14651858:media:CD010156:CD010156-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Vitamin C versus allopurinol, Outcome 1: Serum uric acid reduction" data-id="CD010156-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_t/tCD010156-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Vitamin C versus allopurinol, Outcome 1: Serum uric acid reduction</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/references#CD010156-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010156-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/urn:x-wiley:14651858:media:CD010156:CD010156-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Vitamin C versus allopurinol, Outcome 2: sUA reduction (subgroup analysis)" data-id="CD010156-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_t/tCD010156-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Vitamin C versus allopurinol, Outcome 2: sUA reduction (subgroup analysis)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/references#CD010156-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/media/CDSR/CD010156/image_n/nCD010156-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010156-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Skim milk enriched with GMP/G600 compared with skim milk, plus lactose powder for chronic gout</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Skim milk enriched with GMP/G600 compared with skim milk, plus lactose powder for chronic gout</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with chronic gout </p> <p><b>Settings:</b> outpatients, community </p> <p><b>Intervention:</b> skim milk enriched with glycomacropeptides (GMP)/G600 </p> <p><b>Comparison:</b> skim milk or lactose powder (data from 2 groups combined) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Skim milk and lactose powder</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Skim milk enriched with GMP/G600</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Acute gout flares</b><br/>Participant self‐report, using gout flare diary<br/>Follow‐up: 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean acute gout attack frequency in the control groups was<br/><b>0.70 gout flares per month</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean acute gout attack frequency in the intervention group was <b>0.21 flares per month lower</b><br/>(0.76 lower to 0.34 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120<br/>(1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute effect 21% lower (76% lower to 34% higher)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study withdrawals due to adverse events</b> </p> <p>Follow‐up: 3 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>138 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>175 per 1000</b><br/>(73 to 417) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.27</b> <br/>(0.53 to 3.03) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120<br/>(1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk difference: 4% more withdrawals (10% fewer to 18% more).</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>sUA acid reduction</b><sup>b</sup> </p> <p>(in mmol/L)</p> <p>Follow‐up: 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean sUA level reduction in the control groups was ‐<b>0.010 mmol/L</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean sUA level reduction in the intervention group was <b>0.01 mmol/L lower</b> </p> <p>(0.04 lower to 0.01 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute reduction 0.01 mmol/L (0.04 lower to 0.01 higher)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Joint pain reduction</b><br/>10‐point Likert scale (0 = no pain)<br/>Follow‐up: 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean joint pain reduction in the control groups was <b>‐0.94 points</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean joint pain reduction in the intervention group was <b>1.03 points lower</b><br/>(1.9 lower to 0.1 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120<br/>(1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk difference: 10% lower (1% lower to 20% lower).</p> <p>NNTB = 10 (5 to 100)<sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant global assessment</b> </p> <p>5‐point Likert scale (5 = excellent)</p> <p>Follow‐up: 3 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Measured and reported in text as improved similarly between groups, but unable to obtain data </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total adverse events</b><sup>d</sup> </p> <p>Follow‐up: 3 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>487 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>472 per 1000</b><br/>(321 to 706) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.97</b> (0.66 to 1.45) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120<br/>(1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk difference: 1% less adverse events (1% fewer to 2% more).</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Tophus regression</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>HAQ:</b> Health Assessment Questionnaire; <b>RR:</b> risk ratio; <b>sUA:</b> serum uric acid. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>There was a possible influence of selection and detection bias. In addition, the imprecision of the results (in relation to the small size study) contributed to downgrading the quality of the results. Selective reporting of post hoc comparisons between skim milk powder enriched with GMP/G600 and one of the two study controls (lactose) in relation to change in gout attack frequency from baseline were noted, but it was controlled after the raw data were provided by the study authors.<br/><sup>b</sup>Data regarding sUA normalisation not reported.<br/><sup>c</sup>Number needed to treat for an additional beneficial outcome (NNTB) for continuous outcomes calculated using the Wells calculator software available from the Cochrane Musculoskeletal Group editorial office.<br/><sup>d</sup>Gastrointestinal adverse events (diarrhoea, nausea and flatulence) reported most commonly. There were no serious adverse events that resulted in hospital admissions due to the study products. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Skim milk enriched with GMP/G600 compared with skim milk, plus lactose powder for chronic gout</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/full#CD010156-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010156-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Vitamin C compared with allopurinol for chronic gout</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Vitamin C compared with allopurinol for chronic gout</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> peoeple with chronic gout and sUA level &gt; 0.36 mmol/L </p> <p><b>Settings:</b> outpatients, rheumatology clinics </p> <p><b>Intervention:</b> vitamin C </p> <p><b>Comparison:</b> allopurinol </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Allopurinol</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Vitamin C</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Acute gout flares</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study withdrawals due to adverse events</b> </p> <p>Follow‐up: 8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>sUA reduction</b> </p> <p>Follow‐up: 8 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean sUA reduction in the control group was <b>0.118 mmol/L</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean sUA reduction in the intervention group was <b>0.10 mmol/L</b> less reduction (0.06 to 0.15) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute difference: 10% higher (6% higher to 15% higher)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Joint pain reduction</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant global assessment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total adverse events</b> </p> <p>Follow‐up: 8 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>None reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>None reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None reported. No participants developed oxalate renal stones or oxalosis</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Tophus regression</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>sUA:</b> serum uric acid. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Potential selection, performance, and detection bias might influence the results, as it is an open trial; downgraded twice for bias. No imprecision in data reporting was noted. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Vitamin C compared with allopurinol for chronic gout</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/full#CD010156-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010156-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Skim milk powder (SMP; GMP/G600) versus control (SMP/lactose)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Acute gout flares (per month, after 3 months of treatment) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.76, 0.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Study withdrawals due to adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.53, 3.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Serum uric acid reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.04, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Joint pain reduction (during gout flares) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.03 [‐1.89, ‐0.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Total number of adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.66, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Physical function <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.14, 0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.23, 7.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Skim milk powder (SMP; GMP/G600) versus control (SMP/lactose)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/references#CD010156-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010156-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Vitamin C versus allopurinol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Serum uric acid reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [0.06, 0.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 sUA reduction (subgroup analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [0.02, 0.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 Not on allopurinol at study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [0.08, 0.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 On allopurinol at study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.01, 0.13]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Vitamin C versus allopurinol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010156.pub3/references#CD010156-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010156.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD010156-note-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD010156-note-0014">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010156-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010156-note-0012">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD010156-note-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD010156-note-0009">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD010156-note-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD010156-note-0013">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD010156-note-0007">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD010156-note-0006">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010156\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010156\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010156\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010156\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010156\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010156\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010156\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010156\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010156\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010156\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010156\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010156\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010156\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010156\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010156\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010156\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010156\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010156\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=mvgXlmVk&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010156.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010156.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010156.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010156.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010156.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740719767439"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010156.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740719767443"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010156.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918df0cc9d379371',t:'MTc0MDcxOTc2Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 